Revealing the Mechanism of Xist-mediated Silencing by Chen, Chun-Kan
Revealing the Mechanism of Xist-mediated 
Silencing 
 
 
Thesis by 
Chun-Kan Chen 
 
In Partial Fulfillment of the Requirements for 
the degree of 
Doctor of Philosophy 
 
 
 
 
CALIFORNIA INSTITUTE OF TECHNOLOGY 
Pasadena, California 
 
2018 
Defended  November 1, 2017
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2017 
Chun-Kan Chen 
ORCID: 0000-0002-1194-9137 
 iii 
ACKNOWLEDGEMENTS 
First of all, I’d like to thank my great mentor, Dr. Mitch Guttman (California Institute of 
Technology, Pasadena, CA), who led me to become an independent researcher and gave me 
valuable advice that guided me to accomplish this thesis. He has always been supportive of 
my future plans and career goals. I really enjoyed every discussion we have had. We often 
generated some interesting ideas for projects during our discussions. I would also like to send 
my thanks to my lab mates, Amy Chow, Mario Blanco, and Erik Aznauryan, who helped me 
with many experiments to move the project forward. I’d like to acknowledge Dr. Kathrin 
Plath (University of California, Los Angeles, Los Angeles, CA) for the collaboration and his 
critical comments on this project. Also, I want to thank Jesse Engreitz and Patrick McDonel, 
who provided helpful comments and suggestions to the project. 
I want to thank my parents, brother, and parents-in-law who provided both instrumental and 
emotional support to assist me in completing my Ph.D. degree. I also want to thank my 
friends, Lily Chen, Pei-Ying Lin, Tzu-Yao Wang, and Wei Li, for giving me valuable social 
support during my years in graduate school. 
Last but not least, I would like to send my special thanks to my wife, Christine Juang, who 
has always been supportive. She always encouraged me to pursue my goal, even though 
sometimes it meant going to the lab with me on weekends and waiting with me doing 
experiments for several hours. Her support enabled me to overcome the obstacles I have 
encountered these years, and made me to have what I have achieved today. I am truly grateful 
for all your support. Thank you.
  
iv 
ABSTRACT 
Xist initiates XCI by spreading across the future inactive X-chromosome, excluding RNA 
polymerase II, recruiting the polycomb repressive complex and its associated repressive 
chromatin modifications, and repositioning active genes into a transcriptionally silenced 
nuclear compartment. While much is known about the events that occur during XCI, the 
mechanism by which Xist carries out these various roles remains unclear. Here we identify 
ten proteins that directly associate with Xist, and we further show that three of these proteins 
are required for Xist-mediated transcriptional silencing. One of these proteins, SHARP, 
which is known to interact with the SMRT co-repressor that activates HDAC3, is not only 
essential for silencing, but is also required for the exclusion of PolII from the inactive X. We 
show that both SMRT and HDAC3 are required for Xist-mediated silencing and RNA 
polymerase II exclusion. Another of these proteins, LBR, is required for repositioning 
actively transcribed genes into the Xist-silenced compartment. We further show that Xist, 
through its interaction with LBR, a protein that is anchored in the inner nuclear membrane, 
would effectively reposition Xist-coated DNA to the nuclear lamina, thereby changing the 
accessibility of other genes on the X-chromosome to enable Xist to spread to active genes 
across the entire chromosome to silence chromosome-wide transcription. Together, these 
results present an integrative picture of how Xist can scaffold multiple proteins to orchestrate 
the complex functions required for the establishment of the inactive X-chromosome. 
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C h a p t e r  1  
INTRODUCTION 
1.1 X Chromosome Inactivation 
In mammals, males and females carry a different number of X chromosomes. Females have 
two X chromosomes, while males have one X and one Y chromosome(1). The X 
chromosome is larger and carries many genes, while the Y chromosome is smaller and 
carries much fewer genes(2, 3). In this case, females would seem to express twice the 
amount of the X-linked genes in comparison to males. Therefore, to compensate for the 
dosage difference between males and females, one of the two X chromosomes in females 
is transcriptionally inactive during early development, and the inactive state is inherited 
throughout cell division(1, 4). This process, or X-chromosome inactivation (XCI), is 
essential for proper embryo development of females. Failure of proper XCI will lead to 
sex-differential embryo lethality(5). XCI is found in all mammals, but has not yet been 
found in other groups of animals, such as Drosophila or C. elegans, in which they 
compensate the dosage difference of X chromosome with different mechanisms(6, 7). 
In female mice, XCI occurs in two waves during early development. The first wave, 
imprinted XCI, occurs around 4-8 cell stage, where the paternal X chromosome (Xp) is 
transcriptionally inactive at this stage(8-10). The inactive state of Xp is reversed to active 
at the blastocyst stage, followed by the second wave of XCI, random XCI, where either the 
maternal X chromosome (Xm) or Xp is transcriptionally silenced(11, 12). Once the 
  
2 
inactive state of either Xm or Xp is established, the inactive state of the chromosome is 
maintained throughout cell division, except for some specific cell types, such as germ 
cells(13). In this thesis, we will mainly focus on the molecular mechanism of the regulation 
of random XCI. 
Chromosome-wide transcriptional silencing on Xi is one of the most significant events 
occurs during XCI. Immunofluorescence staining reveals that RNA polymerase II (PolII) 
is depleted (excluded) from the inactive X chromosome (Xi). PolII exclusion is one of the 
earliest events of XCI, which cause the transcriptional silencing on Xi(14).  In addition to 
the transcriptional silencing, many other events also occur exclusively on Xi. One of them 
is the dramatic change of chromatin structure. From visual observation, Xi forms a dense 
and distinct nuclear compartment known as the Barr body(15). In comparison to the active 
X chromosome (Xa), Xi undergoes chromosome-wide loss of topological association 
domains (TADs) and forms two mega-domains(16, 17). Xi becomes more compact and are 
enriched for heterochromatin structure(18). In addition, the nuclear organization also 
changes during XCI. Xi becomes localized at the periphery of the nucleus, and is associated 
with the nuclear lamina compartment(14, 19). Furthermore, XCI results in a cascade of 
chromatin modification on Xi, such as hypoacetylation of H4, H2A, and H3(20, 21), H3K9 
methylaion(22-25), and macroH2A recruitment(26). Interestingly, the regions contain these 
chromatin modification is associated with the heterochromatin region on Xi(18). XCI also 
leads to the enrichment of some proteins on Xi, such as polycomb repressive complex 1 and 
2 (PRC1/2), which mediates H2AK119Ub and H3K27me3 on Xi respectively(27, 28), and 
SMCHD1, a noncanonical member of the SMC family of chromosomal proteins, which 
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plays an important role in the DNA methylation on Xi(29). Finally, at the later stage of XCI, 
the CpG islands on the promoter region of the silenced genes on Xi are heavily methylated, 
which is crucial to maintain the silencing state of Xi throughout cell division(30, 31).  
  
4 
1.2 Xist/XIST LncRNA is a Key Regulatory Component for the Initiation of XCI 
The regulatory element on X chromosome for the initiation of XCI was identified by 
genetic studies, which was later called the X-inactivation center (XIC)(32, 33). The exact 
location of the XIC on X chromosome was identified by chromosome translocation study, 
where the autosome was silenced when the X chromosome fragment containing the XIC 
was translocated and fused with that autosome(34). This finding also suggesting that the 
XIC alone is sufficient to initiate chromosome-wide silencing even in autosomes. By 
comparing the differential gene expression pattern on Xa and Xi, a gene located within the 
XIC that was exclusively expressed on Xi, the Xi-specific transcript (Xist, or XIST in 
human), was identified(35). Sequence analysis of Xist/XIST RNA showed no conserved 
open reading frame, suggesting that it does not encode for any protein(36), and was later 
characterized as a long non-coding RNA (lncRNA). Imaging analysis showed that 
Xist/XIST RNA is localized in the nucleus and coated the entire Xi(36, 37). The expression 
timing of Xist/XIST RNA coincides with the developmental window of the initiation of 
XCI, suggesting that Xist/XIST RNA may play a role in the initiation of XCI(8).  
Mouse Xist transcript is ~17 kb in length (~21 kb for human XIST) and is 
polyadenylated(36, 38). Mouse female embryonic stem cells (ESCs) carry a heterozygous 
deletion of Xist promoter region or its first exon show skewed allele-specific 
transcriptional silencing; only the wild-type X chromosome is transcriptional silenced and 
becomes Xi, while the X chromosome carries the deletion are always actively transcribed 
and becomes Xa(39, 40). In addition, blocking Xist RNA to coat the X chromosome with 
antisense oligonucleotide analogs also prevents the transcriptional silencing during 
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XCI(41). These results showed that the expression of Xist and its capability of coating the 
X chromosome is required for the initiation of XCI and the chromosome-wide 
transcriptional silencing on Xi. Furthermore, inserting the entire Xist/XIST locus into any 
of the autosomes and driving its expression leads to chromosome-wide transcriptional 
silencing of the autosome(42). In addition, expressing Xist/XIST RNA on the X 
chromosome in male cells results in transcriptional silencing of the X chromosome, which 
eventually leads to cell death due to lack of the X-linked genes expression(43). These 
results showed that Xist/XIST a key regulator of XCI which is necessary and sufficient for 
chromosome-wide transcriptional silencing. 
Intensive studies on the function of Xist/XIST reveal a more extensive role that it plays in 
initiating and regulating XCI. Xist/XIST initiates XCI by spreading across the future inactive 
X-chromosome, excluding RNA PolII, and repositioning active genes into a transcriptionally 
silenced nuclear compartment(14, 44-46). All of these roles – localization, RNA PolII 
exclusion, and repositioning – are required for proper silencing of transcription during the 
initiation of XCI(46). Furthermore, Xist/XIST triggers a cascade of events on the inactive X-
chromosome including recruitment of the polycomb repressive complex and its associated 
H3K27me3 repressive chromatin modifications(27, 47, 48), loss of active acetylation(49-52) 
and methylation(22) chromatin modifications, chromosome-wide compaction(19, 53), and 
repositioning to the nuclear lamina(54, 55). Xist/XIST is also required for the change of 
chromatin structure on Xi. Disrupting proper function of Xist in female mouse ESCs 
resulted in lack of loss of TADs on Xi and no mega-domain formation, leading to a 
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chromatin structure similar to Xa(56). These results showed that Xist/XIST is a key 
component that is essential for initiating and regulating various events during XCI. 
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1.3 The Mechanism of Chromosome-wide Xist/XIST-mediated Transcriptional 
Silencing 
While much is known about the events that occur during XCI, the mechanism by which Xist 
carries out these various roles remains unclear because we still do not know the protein 
complexes that interact with Xist to initiate transcriptional silencing, recruit chromatin-
modifying proteins, compact chromatin structure, and reposition the inactive X-
chromosome(57-59). Over the last two decades, numerous attempts have been made to 
define the protein complexes that interact with Xist(57, 58) and that are required for its 
various roles in XCI24,25 26,27 28,29. Most studies have used prior knowledge of the molecular 
events that occur on the X-chromosome, as well as their timing during the initiation of XCI, 
to define potential Xist-interacting proteins(27, 57, 58, 60). While individual proteins have 
been identified that associate with Xist(60-65), these proteins cannot explain the various 
functional roles mediated by Xist. For example, we still do not know how Xist initiates 
transcriptional silencing: indeed, perturbations of the proteins identified so far, including 
components of the PRC2 complex, have no impact on Xist-mediated transcriptional 
silencing(61, 62, 66, 67).  
The main challenge in deciphering the mechanisms by which Xist, or other lncRNAs, 
function is that there are currently no methods to comprehensively define the proteins that 
interact with a lncRNA in the cell. Currently, the two classes of methods for studying 
lncRNA-protein interactions are immunoprecipitation of a specific protein(60, 68-70) and in 
vitro association between a labeled RNA and cellular lysates(71-77). Both of these 
approaches are limited in their ability to define lncRNA-protein complexes that occur in cells 
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because the immunoprecipitation methods require selecting specific candidate interacting 
proteins to study, and in vitro association methods fail to distinguish between interactions 
that occur in the cell from those that occur in solution (25, 68, 77). Accordingly, defining the 
mechanism of Xist and other lncRNAs requires new approaches that can specifically identify 
the direct lncRNA-interacting proteins in vivo without prior knowledge of their identity. 
Therefore, we decided to develop a method that allows us to identify the direct-interacting 
proteome of a lncRNA of interest. With the method. We will be able to reveal the Xist-
interacting proteins and give us some insights of the mechanism of Xist-mediated silencing. 
In Chapter II, it is demonstrated that a newly developed method, RNA Antisense Purification 
(RAP), can identify the direct interacting proteins of Xist in vivo, and a screening system that 
identifies three proteins which are essential for Xist-mediated silencing.  
In Chapter III, it is demonstrated that one of these essential proteins, SHARP, is required for 
Xist-mediated silencing through excluding PolII from Xist-coated territory.  
In Chapter IV, it is demonstrated that another essential protein, LBR, is required for Xist-
mediated silencing through recruiting Xist-associated DNA to nuclear lamina that enables 
Xist to spread across the entire chromosome.  
Chapter V is the discussion of a proposed model of the mechanism of Xist-mediated silencing 
based on the findings of this thesis, and some unanswered questions about Xist and XCI that 
require more studies in the future.  
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C h a p t e r  2  
RAP-MS IDENTIFIES DIRECT XIST-INTERACTING PROTEINS 
REQUIRED FOR XIST-MEDIATED SILENCING 
The work was first published as: 
McHugh, Colleen A., et al. "The Xist lncRNA directly interacts with SHARP to silence 
transcription through HDAC3." Nature 521.7551 (2015): 232. 
2.1    RAP-MS: A Method to Identify the Proteins that Interact with lncRNAs in vivo  
In order to characterize the mechanism of Xist-mediated silencing and define the functions 
of other lncRNAs, a new method that can identify the direct-interacting proteins of a lncRNA 
of interest is essential. To develop a method for identifying the proteins that directly interact 
with a specific lncRNA in vivo, we adapted our RNA Antisense Purification (RAP) 
method(1) to purify a lncRNA complex and identify the interacting proteins by quantitative 
mass spectrometry (RAP-MS) (Methods, Figure 2.1a). Specifically, we used UV 
crosslinking to create covalent linkages between directly interacting RNA and protein(2), 
then purified lncRNAs in denaturing conditions to disrupt non-covalent interactions(3, 4). 
This approach, utilized by methods such as CLIP(4), is known to separate interactions that 
occur in the cell from those that merely associate in solution(3, 5). 
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Adapting this UV-crosslinking and denaturing approach to enable purification of a specific 
lncRNA is challenging for several reasons: (i) In order to purify lncRNA complexes in 
denaturing conditions, we need an RNA capture method that can withstand harsh denaturing 
conditions. (ii) In order to detect the proteins associated with a given lncRNA, we need to 
achieve high purification yields of a lncRNA complex because, unlike nucleic acids, we 
cannot amplify proteins prior to detection. (iii) Because any individual RNA is likely to be 
present at a very low percentage of the total cellular RNA, we need to achieve high levels of 
enrichment to identify specific interacting proteins. (iv) Because the number of background 
proteins will be high, even after enrichment, we need accurate and sensitive methods for 
protein quantification to detect specific lncRNA interacting proteins. 
The RAP-MS method addresses these challenges because (i) RAP uses long biotinylated 
antisense probes, which form very stable RNA-DNA hybrids, and therefore can be used to 
purify lncRNA complexes in denaturing conditions (4M urea and 500 mM lithium chloride 
at 67˚C). Also, (ii) we optimized the RAP method to achieve high yields of endogenous RNA 
complexes. In our original protocol(1), we achieved <2% yield of the endogenous RNA 
complex; by optimizing hybridization, washing, and elution conditions, we were able to 
reproducibly achieve ~70% yield (Figure 2.1b). (iii) Using our optimized conditions, we 
increased the enrichment levels for the target lncRNA complex (~5,000-fold) relative to our 
already high levels of enrichment achieved previously (~100-fold)(1) (Figure 2.1c). (iv) To 
achieve sensitive quantification and to distinguish between specific proteins and background 
proteins, we used Stable Isotope Labeling by Amino acids in Culture (SILAC)(6) to label 
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proteins (Methods), which enables quantitative comparisons of purified proteins by mass 
spectrometry(7-9).  
We validated the RAP-MS approach by defining the proteins that interact with two well-
characterized non-coding RNAs: (i) U1 small nuclear RNA, a core component of the 
spliceosome(10) and (ii) 18S ribosomal RNA, a component of the small ribosomal 
subunit(11). In the U1 purifications, we identified 9 enriched proteins, all of which are known 
to interact with the U1 snRNA. The list includes 7 of the 10 proteins that made up the core 
U1 snRNP complex (U1-A, U1-C, U1-70K, Sm-B, Sm-D2, Sm-D3, Sm-E)(12) as well as 
the Gemin5 processing factor involved in U1 snRNP biogenesis(13) (Figure 2.1d). The ninth 
enriched protein, SF3a1, had not previously been identified as a U1-interacting protein but 
was recently shown to interact directly with the U1 snRNA in vivo(14). In the 18S 
purification, we identified 105 enriched proteins; 98 of these (93%) were previously 
characterized as ribosomal proteins, ribosomal processing and assembly factors, translational 
regulators, or other known ribosome interactors (Figure 2.1d). In particular, we identified 
21 of the 31 known small ribosomal subunit proteins. The U1 and 18S proteins that were 
missed appear to fall predominately into two categories: (i) proteins that make few direct 
contacts with the RNA, and (ii) small proteins that contain only a single possible peptide that 
could be detected by mass spectrometry.  
Together, these results demonstrate that the RAP-MS method identifies the majority of 
known RNA interacting proteins, and that the proteins identified by RAP-MS are highly 
specific for the purified lncRNA complex.  
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Figure 2.1. RAP-MS identifies proteins that are known to directly interact with 
specific ncRNAs. (a) A schematic overview of the RAP-MS method. (b) RT-qPCR 
measuring the percentage of the total cellular Xist or 18S recovered after RAP-MS of Xist. 
Values are computed as the amount of each RNA in the elution divided by the amount of 
RNA in the starting (“input”) lysate material. Error bars represent the standard error of the 
mean from 5 biological replicates. (c) Enrichment of Xist after RAP-MS captures from 
pSM33 cells as measured by qPCR. Bars indicate RNA levels of Xist, 18S, and Oct4 after 
purification of Xist, normalized to RNA in input sample. Each bar represents the RNA 
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levels of Xist, 18S, and Oct4 after purification of Xist, normalized to RNA in input 
sample, from 3 biological replicates. (d) SILAC ratios of top proteins enriched in the RAP-
MS U1 snRNA, 18S rRNA, and 45S pre-rRNA experiments. 
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2.2    RAP-MS Identifies Direct Xist-interacting Proteins 
To define the proteins that interact with the Xist lncRNA during the initiation of XCI, we 
performed RAP-MS in a male mouse embryonic stem (ES) cell line containing a 
doxycycline-inducible Xist after six hours of induction(1) (Methods). This system is known 
to represent a well-synchronized and accurate model for the initiation of XCI(1, 15-17). We 
performed RAP in nuclear extracts from UV-crosslinked SILAC-labeled cells using probes 
that are antisense to the Xist RNA and achieved a ~5,000-fold enrichment of the Xist RNA 
relative to its level in total nuclear RNA (Methods, Figure 2.1b). To control for background 
proteins or non-specific proteins that might interact with any nuclear RNA, we separately 
purified the abundant U1 snRNA, which is not expected to interact with the same proteins as 
Xist. We identified the proteins in each sample using liquid chromatography-mass 
spectrometry and calculated a SILAC ratio for each protein based on the intensity of all heavy 
or light peptides originating from the Xist or U1 purification.  
We identified 10 proteins that were specifically enriched in the Xist purification compared 
to the U1 purification (SILAC ratio >8-fold, Methods, Figure 2.2a). Nearly all of these 
proteins were reproducibly enriched in multiple Xist purifications from independent 
biological samples; the sole exception was missed only because its enrichment level (4-fold) 
fell below our stringent enrichment cutoff (8-fold) in some replicate samples (Methods). 
Consistent with the notion that these proteins are direct Xist RNA-interacting proteins, 9 of 
these proteins contain a well-characterized RNA binding domain (Figure 2.2b). 
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The identified Xist-interacting proteins are SHARP, RBM15, MYEF2, CELF1, hnRNPC, 
LBR, SAF-A, RALY, hnRNPM, and PTBP1. Interestingly, SAF-A (also called hnRNPU) 
was previously shown to interact directly with Xist by UV-based CLIP experiments(18) and 
is required for tethering Xist to the inactive X-chromosome in differentiated cells(18-20). In 
addition, 5 of these proteins have been previously implicated in transcriptional repression, 
chromatin regulation, and nuclear organization (Figure 2.2b). These include the SMRT and 
HDAC Associated Repressor Protein (SHARP, also called SPEN), a member of the SPEN 
family of transcriptional repressors that directly interacts with the SMRT (also called NCoR-
2) component of the nuclear co-repressor complex(21, 22) to activate HDAC3 deacetylation 
activity on chromatin(23). Interestingly, we also identified RBM15, another member of the 
SPEN family of transcriptional repressors, which shares the same domain structure as 
SHARP(24), but appears to have a distinct functional role during development(25, 26). 
Myef2 has been shown to function as a negative regulator of transcription in multiple cell 
types, although its mechanism of regulation is still unknown(27, 28). hnRNP-M is a paralog 
of Myef2. Finally, we identified the Lamin B receptor (LBR), a protein that contains 8 
transmembrane domains that are anchored in the inner nuclear membrane(29-31), a domain 
that interacts with repressive chromatin regulatory proteins(29, 32, 33), and an independent 
domain that interacts with Lamin B(29, 30). 
To confirm that these proteins reflect specific interactions with Xist, and are not due to non-
specific purification of other RNAs, we performed RAP using the same Xist probes in 
uninduced cells in which Xist is not expressed. Furthermore, to confirm that the identified 
interactions represent proteins that are crosslinked to Xist in vivo rather than interactions that 
  
24 
form in solution, we purified Xist from cells that were not crosslinked (no UV light). In 
both cases, we identified none of these 10 Xist-interacting proteins, nor any other specifically 
enriched proteins in either of these control samples (Methods), demonstrating that the 
identified proteins are covalently crosslinked to Xist in cells.  
Finally, we tested whether we could enrich Xist RNA using UV-crosslinking and 
immunoprecipitation of the identified proteins (Methods). We tested 5 of the 10 identified 
proteins, for which we could obtain high-quality IP-grade antibodies (Ptbp1, hnRNPC, 
RBM15, LBR, and RALY), along with several negative controls (IGG and Pum1). In all 5 
cases, we observed a strong enrichment for Xist RNA relative to total input RNA levels 
(Figure 2.2c, d). Notably, we did not observe any enrichment for Xist in the negative 
controls, nor did we observe enrichment of mRNAs (i.e. Oct4 or Nanog) or other nuclear 
lncRNAs (i.e. Neat1) (Figure 2.2e, f).   
Together, these results identify a set of highly specific and reproducible proteins that directly 
interact with Xist during the initiation of XCI. Given the generality of the RAP-MS approach, 
we expect that it will be broadly applicable for defining the protein complexes that interact 
with other lncRNAs. 
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Figure 2.2. RAP-MS identifies direct Xist-interacting proteins. (a) The SILAC ratio 
(Xist/U1) for each Xist-enriched protein identified by RAP-MS for one representative 
sample of four biological replicates. For SHARP and RBM15, the enrichment values are 
indicated above their bars. (b) Each Xist-interacting protein is shown (scaled to protein 
length). The locations of functional domains are shown. (c) Enrichment of the Xist lncRNA 
after immunoprecipitation from a sample of pSM33 male cells. (d) Immunoprecipitation 
of SHARP was performed from a sample of UV-crosslinked females ES cells that were 
treated with retinoic acid for 24 hours. The levels of recovered Xist lncRNA (black bars), 
Neat1 lncRNA (white bars), and 45S pre-ribosomal RNA (gray bars) were measured by 
RT-qPCR. Enrichment of each RNA after capture with anti-SHARP antibody was 
calculated relative to the level of RNA captured with IgG control antibody. (e) The 
enrichment of various lncRNAs after immunoprecipitation in pSM33 male cells – 
including Neat1, Malat1, Firre, and Tug1 – are shown. (f) The enrichment of various 
mRNA controls after immunoprecipitation in pSM33 male cells – including Oct4, Nanog, 
Stat3, and Suz12 – are shown.   
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2.3    SHARP, LBR, and SAF-A are required for Xist-mediated silencing 
Having defined the direct Xist-interacting proteins, we sought to determine which Xist-
interacting proteins are required for Xist-mediated transcriptional silencing on the inactive 
X-chromosome. To do this, we knocked down each of the identified proteins prior to Xist 
induction and assayed for the failure to silence gene expression on the X-chromosome upon 
induction of Xist expression (Figure 2.3a). 
Specifically, we selected two X-linked genes, Gpc4 and Atrx, that are well expressed in the 
absence of Xist expression, but are normally silenced by 16 hours of Xist induction in our 
doxycycline-inducible system in male cells (Figure 2.3b, c). This male-inducible system is 
more sensitive for identifying proteins that affect silencing compared to a female system 
because Xist-mediated silencing in males will lead to loss of 100% of X-chromosome 
transcripts rather than only 50% in a female system, which still retains one active X. We used 
siRNAs to knock down the mRNA levels of each of the proteins identified by RAP-MS along 
with several negative controls (Methods). We ensured that each cell examined showed both 
successful depletion of the siRNA-targeted mRNA as well as induction of Xist expression 
using single molecule RNA FISH(34) (Methods). We observed no difference in the 
percentage of cells that induce Xist expression in any of the siRNA conditions relative to 
untreated cells. Within each of these cells, we quantified the mRNA level of each of the two 
X-linked genes prior to Xist induction (-dox) and after Xist induction (+dox). 
As a control, we transfected several non-targeting siRNAs (Methods). In these negative 
controls, we observed the expected silencing of the X-linked genes studied (Gpc4 expression 
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decreased from an average of 20 copies (-dox) to 2 copies (+dox) per cell and Atrx 
expression decreased from 22 to 3 copies per cell; Figure 2.3d). Similarly, knock down of 
Rbm15, Myef2, Ptbp1, Celf1, hnRNPC, Raly, or hnRNPM did not alter gene silencing on 
the X-chromosome (Figure 2.3b, e). Consistent with previous observations, we also 
observed no effect on X-chromosome gene silencing upon knock down of EED42,43, a 
component of PRC2 that is required for its localization and activity on chromatin(35, 36) 
(Figure 2.3b, e).  
In contrast, knock down of SHARP, Lamin B Receptor (LBR), or SAF-A largely abolished 
the silencing of X-chromosome genes following Xist induction (Figure 2.3b, e). Indeed, the 
expression levels of the X-chromosome genes studied did not significantly change following 
Xist expression (Figure 2.3b, c), indicating that SHARP, LBR, and SAF-A are required for 
Xist to initiate transcriptional silencing on the X-chromosome.  
Since previous studies have shown that Xist can no longer initiate transcriptional silencing 
after a certain critical window during differentiation(16), we wanted to ensure that the loss 
of Xist silencing upon knock down of SHARP, LBR, and SAF-A was not merely due to 
cellular differentiation. To address this, we performed single molecule FISH for Gpc4 
mRNA along with immunofluorescence for Nanog, a marker of the pluripotent state that is 
rapidly lost upon differentiation(37). We confirmed that knockdown of SHARP, LBR, or 
SAF-A also abolished gene silencing on the X-chromosome in Nanog-positive cells (Figure 
2.3f). 
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To ensure that these silencing defects were not specific to our inducible male ES cell 
system, we knocked down SHARP, LBR, or SAF-A along with several controls in wild-type 
female ES cells and induced Xist expression through retinoic acid-mediated differentiation 
(Methods). In the negative controls, we observed silencing of X-chromosome genes upon 
induction of Xist (30 to 14 copies of Gpc4). Consistent with our previous observations, knock 
down of SHARP, LBR, or SAF-A led to a loss of gene silencing on the X-chromosome, 
whereas knock down of EED had no effect on gene silencing within cells that induce Xist 
expression (Figure 2.3g). 
Since SAF-A was previously shown to be required for Xist localization to chromatin in 
differentiated cells(18), we hypothesized that the observed SAF-A silencing defect might be 
because it is required for Xist localization to the X-chromosome during initiation of XCI. To 
test this, we looked at the Xist distribution in the nucleus in all of these perturbations. 
Consistent with previous observation, we observed a diffuse Xist localization pattern in the 
nucleus upon knock down of SAF-A, but not in any other control or protein knock down 
(Figure 2.3f). This suggests that SAF-A is required for localizing Xist and its silencing 
proteins to the X-chromosome. 
Together, these results demonstrate that SHARP, LBR, and SAF-A are required for the 
initiation of Xist-mediated transcriptional silencing of the X-chromosome. Although the 
remaining seven Xist-interacting proteins showed no effect on X-chromosome gene 
silencing, they may still be important for Xist function: (i) some may have redundant 
functions (e.g. Myef2 and hnRNP-M, which are known paralogs), (ii) in some of these cases, 
the small amount of protein remaining after knock down may still be sufficient for Xist 
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function, or (iii) some of these proteins may be important for alternative Xist-mediated 
roles, such as the maintenance of XCI, which would not be captured by this silencing assay. 
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Figure 2.3. SHARP, LBR, and SAF-A are required for Xist-mediated gene silencing. 
(a) Screen for Xist-mediated gene silencing for knockdown of control (top), non-silencing 
proteins (middle), or silencing proteins (bottom). (b) Gpc4 mRNA levels after induction of 
Xist (+dox) normalized to Gpc4 levels before Xist induction (-dox). Error bars: standard 
error of the mean across 50 cells from one experiment. siCtrl: scrambled siRNA control. (c) 
Images of individual cells for two X-linked mRNAs, Gpc4 (green) and Atrx (red), and DAPI 
(blue) after treatment with different siRNAs (rows). The number of identified mRNAs is 
shown. (d) Quantification of the copy number of Gpc4 before and after Xist induction upon 
treatment with different siRNAs. (e) Quantification of the copy number of Gpc4 in –Dox and 
+Dox cells after knockdown with siRNAs targeting different mRNAs. (f) Knockdown of 
SHARP, LBR, or SAF-A abrogates Xist-mediated gene silencing without causing 
pluripotency defects. Representative images showing staining of Nanog (cyan), Xist (red), 
and Gpc4 (green) upon knockdown of SHARP, LBR or SAF-A after 16 hours of Xist 
induction with doxycycline. (g) Quantification of the copy number of Gpc4 for –RA and 
+RA cells upon transfection with different siRNAs. Error bars represent the standard error 
across 50 individual cells from one experiment. Error bars represent the standard error of the 
mean across 50 individual cells from one experiment. NS: not significantly different, **** 
represents values with a p-value<0.001, ** represents values with a p-value<0.01, and * 
represents values with a p-value<0.05 between +Dox and –Dox, or +RA and –RA, cells 
based on an unpaired two-sample t-test. Scale bars on the images represent 5 μm. 
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Methods 
Mouse ES cell culture 
All mouse ES cell lines were cultured in serum-free 2i/LIF medium as previously 
described(1). We used the following cell lines: (i) Wild-type male ES cells (V6.5 line);  (ii) 
Male ES cells expressing Xist from the endogenous locus under control of a tet-inducible 
promoter (pSM33 ES cell line) as previously described(1). (iii) Male ES cells carrying a 
cDNA Xist transgene without the A-repeat integrated into the Hprt locus under control of the 
tet-inducible promoter (A-repeat deletion: kindly provided by A. Wutz)(15). (iv) Female ES 
cells (F1 2-1 line). This wild-type female mouse ES cell line is derived from a 129 x 
castaneous F1 mouse cross as previously described(1).  
Xist induction 
For Dox inducible cells (pSM33 and A-repeat deletion), we induced Xist expression by 
treating cells with 2 μg/ml doxycycline (Sigma) for 6 hours, 16 hours, or 24 hours based on 
the application. For female ES cells (F1 2-1 line), we induced Xist expression by inducing 
differentiation; 2i was replaced with MEF media (DMEM, 10% Gemini Benchmark FBS, 
1× L-glutamine, 1× NEAA, 1× Pen/Strep; Life Technologies unless otherwise indicated) for 
24 hours followed by treatment with 1 μM retinoic acid (RA) (Sigma) for an additional 24 
hours. 
We measured the amount of Xist RNA in both the doxycycline-inducible cells (6 hours 
induction) and differentiating female ES cells (24 hour induction) by qRT-PCR. We 
normalized this level to various RNA housekeeping controls, 18S, 28S, and U6, in both cell 
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populations and calculated the fold expression difference between male and female cells 
using the comparative Ct method. We observed a range of expression, with the male 
inducible system expressing from 5-20 fold (12-fold average) more Xist than the female 
cells. We note that this estimate likely represents an upper limit of the actual differences 
because the female ES cell system is known to be heterogeneous in Xist-induction, such that 
not every cell will induce Xist to the same level after 24 hours of retinoic acid treatment. 
Accordingly, we expect that the actual differences between the male inducible system and 
differentiating female ES cells are actually significantly lower. While the precise levels are 
hard to compare by single molecule FISH, the size and intensity of each Xist RNA cloud is 
similar in both systems at the time points used. 
The male-inducible system is more sensitive for identifying proteins that affect silencing  
compared to a female system because Xist-mediated silencing in males will lead to loss of 
100% of X-chromosome transcripts rather than only 50% in a female system, which still 
retains one active X.  
UV crosslinking 
Cells were washed once with PBS and then crosslinked on ice using 0.8 Joules/cm2 (UV8k) 
of UV at 254 nm in a Spectrolinker UV Crosslinker. Cells were then scraped from culture 
dishes, washed once with PBS, pelleted by centrifugation at 1500 × g for 4 minutes, and flash 
frozen in liquid nitrogen for storage at – 80 ˚C.  
SILAC ES cell culture 
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For SILAC experiments, we adapted our ES cell culture procedures to incorporate either 
light or heavy lysine and arginine amino acids. The 2i/LIF SILAC medium was composed 
as follows: custom DMEM/F-12 without lysine or arginine (Dundee Cell Products) was 
supplemented with either 0.398 mM heavy Arg10 (Sigma) or unlabeled arginine (Sigma) 
and either 0.798 mM heavy Lys8 (Cambridge Isotope Labs) or unlabeled lysine (Sigma), 
0.5× B-27 (Gibco), 2 mg/mL bovine insulin (Sigma), 1.37 μg/mL progesterone (Sigma), 5 
mg/mL BSA Fraction V (Gibco), 0.1 mM 2-mercaptoethanol (Sigma), 5 ng/mL murine LIF 
(GlobalStem), 0.1 μM PD0325901 (SelleckChem) and 0.3 μM CHIR99021 (SelleckChem). 
Cells in both heavy and light 2i/LIF SILAC medium were also supplemented with 0.2 
mg/mL of unlabeled proline (Sigma) to prevent conversion of labeled arginine to proline. 2i 
inhibitors were added fresh with each medium change. 
Adapting cells to SILAC conditions 
Prior to mass spectrometry, ES cells were adapted to SILAC conditions over three passages. 
The heavy or light culture medium was replaced every 24-48 hours depending on cell 
density, and cells were passaged every 72 hours using 0.025% trypsin (Gibco), rinsing 
dissociated cells from the plates with DMEM/F12 containing 0.038% BSA Fraction V 
(Gibco). Cells were grown in two different types of medium: (i) 2i/LIF SILAC medium with 
light (unlabeled) lysine and arginine, or (ii) 2i/LIF SILAC medium with heavy isotope 
labeled lysine and arginine.  
Measuring SILAC incorporation 
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To examine the efficiency of SILAC labeling in pSM33 cells, we tested for the 
incorporation of labeled amino acids after 10 days of growth (3 cell passages) in heavy 2i/LIF 
SILAC medium. Pellets of 2 million cells were boiled for 10 minutes in LDS Sample 
Loading Buffer (Invitrogen) and then proteins were separated by SDS-PAGE on a 4-12% 
Tris-Glycine polyacrylamide gel (Invitrogen). Total protein was stained with Colloidal 
Coomassie (Invitrogen) and gel slices were excised with a clean scalpel and transferred to 
microcentrifuge tubes for in-gel tryptic digest. Protein disulfide bonds were reduced with 
DTT and then alkylated with iodoacetamide. Proteins were digested with trypsin overnight 
and then extracted using successive washes with 1% formic acid/2% acetonitrile, 1:1 
acetonitrile/water, and 1% formic acid in acetonitrile. Peptides were collected, lyophilized, 
and then resuspended in 1% formic acid for mass spectrometry analysis (described below in 
Mass Spectrum Measurements). Peptides were identified from mass spectra using 
MaxQuant (described below in MS data analysis). The incorporation rate of labeled amino 
acids was calculated based on the ratio of the intensity of heavy and light versions of each 
peptide identified. In cells used for subsequent assays, we confirmed that over 95% of 
peptides from cellular proteins showed >95% incorporation of labeled amino acids 
(Extended Data 1b). 
RNA Affinity Purification-Mass Spectrometry (RAP-MS)  
Probe design and generation 
To create the probes used to capture target RNAs, we designed and synthesized 90-mer DNA 
oligonucleotides (Eurofins Operon) that spanned the entire length of the target RNA. The 
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sequence of each DNA oligonucleotide probes was antisense to the complementary target 
RNA sequence. Each DNA oligonucleotide probe was also modified with a 5’ biotin in order 
to enable capture of DNA-RNA hybrids on streptavidin coated magnetic beads (described 
below). While we had previously used 120-mer probes, we found that 90-mer probes 
provided comparable stringency and yield in the conditions used. For Xist, we used 142 
probes that covered the entire mature RNA sequence, with the exception of regions that 
match to other transcripts or genomic regions as previously described(1, 38).  
Total cell lysate preparation  
For the 18S and U1 experiments we used total cellular lysates prepared in the following 
manner. We lysed batches of 20 million cells by completely resuspending frozen cell pellets 
in ice cold detergent-based Cell Lysis Buffer (10 mM Tris pH 7.5, 500 mM LiCl, 0.5% 
dodecyl maltoside (DDM, Sigma), 0.2% sodium dodecyl sulfate (SDS, Ambion), 0.1% 
sodium deoxycholate (Sigma)). Next, 1× Protease Inhibitor Cocktail (Set III, EDTA-free, 
Calbiochem) and 920 U of Murine RNase Inhibitor (New England Biolabs) were added and 
the sample was incubated for 10 minutes on ice to allow lysis to proceed. During this 
incubation period, the cell sample was passed 3-5× through a 26-gauge needle attached to a 
1 mL syringe in order to disrupt the pellet and shear genomic DNA. Each sample was then 
sonicated using a Branson Digital Sonifier with a microtip set at 5 watts power for a total of 
30 seconds in intermittent pulses (0.7 seconds on, 1.3 seconds off). During sonication the 
samples were chilled to prevent overheating of the lysate. The samples were then treated for 
10 minutes at 37 ˚C with 2.5 mM MgCl2, 0.5 mM CaCl2, and 20 U of TURBO DNase 
(Ambion) to digest DNA. Samples were returned to ice and the reaction was immediately 
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terminated by the addition of 10 mM EDTA and 5 mM EGTA. Disulfide bonds were 
reduced by addition of 2.5 mM Tris-(2-carboxyethyl) phosphine (TCEP) and samples were 
then mixed with twice the lysate volume of 1.5× LiCl/Urea Buffer (the final1× Buffer 
contains 10 mM Tris pH 7.5, 5 mM EDTA, 500 mM LiCl, 0.5% DDM, 0.2% SDS, 0.1% 
deoxycholate, 4M urea, 2.5 mM TCEP). Lysates were incubated on ice for 10 minutes and 
then cleared by centrifugation in an Eppendorf 5424R centrifuge for 10 minutes at 16,000 × 
g. Supernatants were pooled and flash frozen in liquid nitrogen for storage at -80 ˚C. 
Nuclear lysate preparation 
For the Xist versus U1 and 45S versus U1 comparisons, we used nuclear lysates prepared in 
the following manner. We lysed batches of 50 million cells by resuspending frozen pellets 
in 1 mL Lysis Buffer 1 (10 mM HEPES pH7.2, 20 mM KCl, 1.5 mM MgCl2, 0.5 mM EDTA, 
1 mM Tris(2-carboxyethyl)phosphine (TCEP), 0.5 mM PMSF). Then the samples were 
centrifuged at 3,300 × g for 10 minutes to pellet cells. The cell pellets were resuspended in 1 
mL Lysis Buffer 1 with 0.1% dodecyl maltoside (DDM) and dounced 20 times using a glass 
dounce homogenizer with the small clearance pestle (Kontes). Nuclei released from the cells 
after douncing were pelleted by centrifugation at 3,300 × g then resuspended in 550 μl Lysis 
Buffer 2 (20 mM Tris pH 7.5, 50 mM KCl, 1.5 mM MgCl2, 2 mM TCEP, 0.5 mM PMSF, 
0.4% sodium deoxycholate, 1% DDM, and 0.1% N-lauroylsarcosine (NLS)). Samples were 
incubated on ice for 10 minutes, and then each sample was sonicated using a Branson 
Sonifier at 5 watts power for a total of 1 minute in intermittent pulses (0.7 seconds on, 3.3 
seconds off) to lyse nuclei and solubilize chromatin. During sonication the samples were 
chilled to prevent overheating of the nuclear lysate. Samples were then treated with 2.5 mM 
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MgCl2, 0.5 mM CaCl2, and 330 U TURBO DNase (Ambion) for 12 minutes at 37 ˚C to 
further solubilize chromatin. After DNase treatment, lysates were mixed with equal volume 
of 2× Hybridization Buffer (the final 1× Buffer contains 10 mM Tris pH 7.5, 5 mM EDTA, 
500 mM LiCl, 0.5% DDM, 0.2% SDS, 0.1% deoxycholate, 4M urea, 2.5 mM TCEP). 
Finally, lysates were cleared by centrifugation for 10 minutes at 16,000 × g in an Eppendorf 
5424R centrifuge and the resulting supernatants were pooled and flash frozen in liquid 
nitrogen for storage at -80 ˚C.  
RNA affinity purification of crosslinked complexes 
Lysates from 200 million or 800 million cells were used for each capture. For 200 million 
cells the following protocol was used, and scaled appropriately for larger cell numbers. For 
each capture, a sample of heavy or light SILAC labeled frozen lysate was warmed to 37 ˚C. 
For each sample, 1.2 mL of Streptavidin Dynabeads MyOne C1 magnetic beads (Invitrogen) 
were washed 6 times with equal volume of hybridization buffer (10 mM Tris pH 7.5, 5 mM 
EDTA, 500 mM LiCl, 0.5% DDM, 0.2% SDS, 0.1% deoxycholate, 4M urea, 2.5 mM TCEP). 
Lysate samples were pre-cleared by incubation with the washed Streptavidin C1 magnetic 
beads at 37 ˚C for 30 minutes with intermittent shaking at 1100 rpm on a Eppendorf 
Thermomixer C (30 seconds mixing, 30 seconds off). Streptavidin beads were then 
magnetically separated from lysate samples using a Dynamag magnet (Life Technologies). 
The beads used for pre-clearing lysate were discarded and the lysate sample was transferred 
to fresh tubes twice to remove all traces of magnetic beads. Biotinylated 90-mer DNA 
oligonucleotide probes specific for the RNA target of interest (20 μg per sample, in water) 
were heat-denatured at 85 ˚C for 3 minutes and then snap-cooled on ice. Probes and pre-
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cleared lysate were mixed and incubated at 67 ˚C using an Eppendorf thermomixer with 
intermittent shaking (30 seconds shaking, 30 seconds off) for 2 hours to hybridize probes to 
the capture target RNA. Hybrids of biotinylated DNA probes and target RNA were then 
bound to streptavidin beads by incubating each sample with 1.2 mL of washed Streptavidin 
coated magnetic beads at 67 ˚C for 30 minutes on an Eppendorf Thermomixer C with 
intermittent shaking as above. Beads with captured hybrids were washed 6 times with 
LiCl/Urea Hybridization Buffer at 67 ˚C for 5 minutes to remove non-specifically associated 
proteins. Between 0.5 – 1% of the total beads were removed and transferred to a fresh tube 
after the final wash to examine RNA captures by qPCR (see “Elution and analysis of RNA 
samples”). The remaining beads were resuspended in Benzonase Elution Buffer (20 mM Tris 
pH 8.0, 2 mM MgCl2, 0.05% NLS, 0.5 mM TCEP) for subsequent processing of the protein 
samples.  
Elution of protein samples 
Elution of captured proteins from streptavidin beads was achieved by digesting all nucleic 
acids (both RNA and DNA, double-stranded and single-stranded) using 125 U of Benzonase 
nonspecific RNA/DNA nuclease for 2 hours at 37 ˚ C (Millipore, #71206-3). Beads were then 
magnetically separated from the sample using a DynaMag magnet (Life Technologies)  and 
the supernatant containing eluted Xist-specific proteins was precipitated overnight at 4 ˚C 
with 10% trichloroacetic acid (TCA). TCA treated protein elution samples were pelleted by 
centrifugation for 30 minutes at >20,000 × g, and then washed with 1 mL cold acetone and 
recentrifuged. Final protein elution pellets were air dried to remove acetone and stored at         
-20 ˚C until processing for mass spectrometry.  
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Elution and analysis of RNA samples 
Beads with hybrids were magnetically separated using a 96-well DynaMag (Life 
Technologies) and the supernatant was discarded. Beads were then resuspended by pipetting 
in 20 μL NLS RNA Elution Buffer (20 mM Tris pH 8.0, 10 mM EDTA, 2% NLS, 2.5 mM 
TCEP). To release the target RNA, beads were heated for 2 minutes at 95 ˚ C in an Eppendorf 
Thermomixer C. Beads were then magnetically separated using a 96-well DynaMag (Life 
Technologies) and the supernatants containing eluted target RNA were digested by the 
addition of 1 mg/mL Proteinase K for 1 hour at 55 ˚C to remove all proteins. The remaining 
nucleic acids were then purified by ethanol precipitation onto SILANE beads (Invitrogen) as 
previously described(1, 38). DNA probes were removed by digestion with TURBO DNase 
(Ambion). To quantify RNA yield and enrichment, qPCR was performed as previously 
described(1).  
Mass Spectrometry Analysis  
Preparation of proteins for mass spectrometry  
Proteins from RAP-MS captures were resuspended in fresh 8 M urea dissolved in 40 μL of 
100 mM Tris-HCl pH 8.5. Disulfide bonds were reduced by incubation with 3 mM TCEP 
for 20 minutes at room temperature, followed by alkylation with 11 mM iodoacetamide for 
15 minutes at room temperature in the dark. Samples were then digested with 0.1 μg 
endoproteinase Lys-C for 4 hours at room temperature. After Lys-C digestion the samples 
were diluted to a final concentration of 2M urea by the addition of 100 mM Tris-HCl pH 8.5, 
and CaCl2 was added to a final concentration of 1 mM. Tryptic peptides were generated by 
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treatment with 0.1 to 0.5 μg of trypsin overnight at room temperature. Contaminating 
detergents were removed from peptides using HiPPR detergent removal columns (Thermo), 
and peptides were protonated by the addition of 5% formic acid before desalting on a Microm 
Bioresources C8 peptide MicroTrap column. Peptide fractions were collected and 
lyophilized, and dried peptides were resuspended in 0.2% formic acid with 5% acetonitrile.  
Mass spectrum measurements  
Liquid chromatography-mass spectrometry and data analyses of the digested samples were 
carried out as previously described(39) with the following modifications. All experiments 
were performed on a nanoflow LC system, EASY-nLC 1000 coupled to a hybrid linear ion 
trap Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) 
equipped with a nanoelectrospray ion source (Thermo Fisher Scientific). For the EASY-nLC 
II system, solvent A consisted of 97.8% H2O, 2% ACN, and 0.2% formic acid and solvent B 
consisted of 19.8% H2O, 80% ACN, and 0.2% formic acid. For the LC-MS/MS experiments, 
200 ng of digested peptides were directly loaded at a flow rate of 500 nL/min onto a 16-cm 
analytical HPLC column (75 μm ID) packed in-house with ReproSil-Pur C18AQ 3 μm resin 
(120 Å pore size, Dr. Maisch, Ammerbuch, Germany). The column was enclosed in a column 
heater operating at 30°C. After 30 min of loading time, the peptides were separated with a 
75 min gradient at a flow rate of 350 nL/min. The gradient was as follows: 0–2% Solvent B 
(5  min), 2–30% B (60 min), and 100% B (10  min). The Elite was operated in data-dependent 
acquisition mode to automatically alternate between a full scan (m/z=400–1600) in the 
Orbitrap and subsequent rapid 20 CID MS/MS scans in the linear ion trap. CID was 
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performed with helium as collision gas at a normalized collision energy of 35% and 10 ms 
of activation time.  
MS data analysis 
Thermo RAW files were searched with MaxQuant (v 1.5.0.30)(40, 41). Spectra were 
searched against all UniProt mouse entries (43,565 entries, downloaded 02 Oct 14) and 
MaxQuant contaminant database (245 entries). Decoy sequences (reversed peptide 
sequences) were generated in MaxQuant to estimate the false discovery rate(42). Search 
parameters included multiplicity of 2 with heavy Arg (+10.0083) and heavy Lys (+8.0142) 
as heavy peptide modifications. Variable modifications included oxidation of Met 
(+15.9949) and protein N-terminal acetylation (+42.0106). Carboxyamidomethylation of 
Cys (+57.0215) was specified as a fixed modification.  Protein and peptide false discovery 
rates were thresholded at 1%. Precursor mass tolerance was 7 ppm (or less for individual 
peptides). Fragment mass tolerance was 0.5 Da. Requantify and match between runs were 
both enabled.  Trypsin was specified as the digestion enzyme with up to 2 missed cleavages.  
Identification of RNA interacting proteins 
Proteins of interest from RAP-MS captures were identified based on several criteria. First, 
proteins were considered identified only if 2 or more unique peptides were found in the mass 
spectrum. Then proteins of interest were selected based on the SILAC ratio of capture versus 
control samples. SILAC ratios for each peptide were calculated based on the intensity ratios 
of heavy and light SILAC pairs. The protein ratio is the median of all calculated peptide 
ratios, with a minimum of two SILAC pairs required for a SILAC ratio to be assigned to a 
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given protein. A SILAC ratio cutoff of ≥3.0 (fold enrichment over control sample) was 
used as a cutoff for further analysis. We excluded known contaminants, including human 
keratin and proteins introduced during the sample purification and preparation process (such 
as streptavidin, Benzonase, and trypsin), as well as naturally biotinylated proteins that 
contaminate the preparation by binding to streptavidin beads.  
RAP-MS experiments and controls 
18S rRNA versus U1 snRNA  
To validate the RAP-MS method and identify proteins specifically interacting with 18S 
ribosomal RNA or U1 snRNA, we performed captures of each target RNA in parallel 
samples from heavy and light labeled lysates from wild-type V6.5 ES cells. The total protein 
quantity in elution samples from each RAP-MS capture was measured by comparing the 
median intensity of peptides identified in a single quantitation MS run for each sample. The 
heavy and light label swapped samples were then mixed equally based on total protein 
quantity and analyzed by mass spectrometry to identify the SILAC enrichment ratio of 
proteins originating from 18S rRNA or U1 snRNA captures. The experiment was performed 
twice and each experimental set contained two biological replicates of 18S and U1 captures 
(heavy and light labeling states).  
Xist lncRNA versus U1 snRNA captures 
To identify proteins specifically interacting with Xist lncRNA, we performed captures as 
described above with either 200M cells or 800M pSM33 cells treated with doxycycline for 
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6 hours. The total protein quantity in elution samples from each RAP-MS capture was 
measured by a single quantitation MS run for each sample. Heavy and light label swapped 
samples were mixed equally based on total protein quantity, and analyzed by mass 
spectrometry. SILAC ratios of Xist enriched proteins versus U1 enriched proteins were 
calculated and used to identify Xist-specific interacting proteins for further analysis. The 
experiment was performed twice and each experimental set contained two biological 
replicates of Xist and U1 captures, from heavy and light labeled samples. Proteins replicated 
well between samples, with a sole exception (LBR) that was missed only because its 
enrichment level (2-fold) fell below our enrichment cutoff (3-fold) in some replicate samples.  
Xist lncRNA capture from non-crosslinked cells 
As a control to ensure that purified proteins are not non-specifically associated or binding in 
vitro with target RNAs during capture, we performed RAP-MS captures of Xist from non-
crosslinked cells otherwise treated in the same manner (i.e. doxycycline treated for 6 hours).  
Xist lncRNA capture from cells where Xist is not expressed  
To confirm that the identified proteins are not resulting from background proteins or probe 
association with other RNAs or proteins in the pSM33 cells, we performed RAP captures of 
Xist from pSM33 cells that were not treated with doxycycline, but which were otherwise 
treated identically.  
45S pre-rRNA capture versus U1 capture 
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To ensure that the proteins enriched in Xist captures using RAP-MS are not simply due to 
increased protein capture as a consequence of long target RNA transcripts, we additionally 
performed captures of the 13,000 nucleotide long 45S pre-ribosomal RNA as a control. To 
ensure specific capture only of the 45S, and not the mature 18S and 28S, we designed probes 
that specifically targeted the internal transcribed spacer regions (ITS1 and ITS2) that are only 
present in the 45S pre-ribosomal RNA.  The experiment was performed in the same manner 
and with the same conditions as the Xist lncRNA captures described above. To compare Xist 
protein enrichment to 45S protein enrichment, we used a SILAC approach based on direct 
comparison of two samples that share a common denominator (called spike-in SILAC(43)). 
Specifically, we calculated an overall Xist/45S SILAC ratio by multiplying the Xist/U1 ratio 
by the U1/45S ratio for each identified protein.  
Protein domain classification 
We defined the conserved domain structures of proteins using the Protein Families database 
(Pfam(44)).  
RNA Immunoprecipitation in UV-crosslinked cells 
We crosslinked pSM33 cells after 6 hours of doxycycline-treatment with 0.4 Joules/cm2 of 
UV254. Cells were lysed and RNA was digested with RNase I to achieve a size range of 100-
500 nucleotides in length. Lysate preparations were precleared by mixing with Protein G 
beads for 1 hour at 4 ˚C. For each sample, target proteins were immunoprecipitated from 20 
million cells with 10 μg of antibody (Supplementary Table 1) and 60 μl of Protein G 
magnetic beads (Invitrogen). The antibodies were pre-coupled to the beads for 1 hour at room 
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temperature with mixing before incubating the precleared lysate to the antibody-bead 
complexes for 2 hours at 4 ˚C. After the immunoprecipitation, the beads were rinsed with a 
wash buffer of 1× PBS with detergents. After a dephosphorylation treatment, the RNA in 
each sample was ligated to a mixture of barcoded adapters in which each adapter had a unique 
barcode identifier. After ligation, beads were rinsed with 1× PBS and detergents and then 5× 
PBS (750 mM NaCl) and detergents prior to pooling 3-4 antibodies in a new tube. The 
proteins and RNA were then eluted from the Protein G beads with 6 M urea and 40 mM DTT 
at 60 °C. Protein-RNA complexes were separated away from free RNA by covalently 
coupling proteins to NHS-magnetic beads (Pierce) and washing 3 times in 6 M GuSCN 
(Qiagen RLT buffer) and heating in 1% NLS at 98 °C for 10 minutes. The proteins were then 
digested with Proteinase K and RNA was purified for subsequent analysis. From the 
barcoded RNA in each pool, we generated Illumina sequencing libraries as previously 
described(38). We saved a small percentage (~1%) of starting material prior to 
immunoprecipitation and processed and sequenced this sample in parallel. 
Analysis of crosslinked RNA Immunoprecipitation Data 
We computed the enrichment for any RNA upon immunoprecipitation with a specific protein 
relative to its total levels in the cell. To do this, we counted the total number of reads 
overlapping the RNA in either the immunoprecipitation sample or the input control. To 
account for differences in read coverage between samples, each of these numbers was 
normalized to the total number of reads within the same experiment. This generates a 
normalized score, per RNA, within each sample. We then computed an enrichment metric 
by taking the ratio of these normalized values (IP/Input). We then compared these enrichment 
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levels across different proteins and controls (i.e. IgG). To enable direct comparison across 
proteins for a given gene, we need to account for differences in the protein specific 
background level, which may occur to differences in IP efficiency or non-specific binding of 
each antibody. To do this, we computed a normalized enrichment ratio by dividing the ratio 
for each gene by the average ratio across all genes for a given protein, as previously 
described(45).  
To exclude the possibility of promiscuous binding to all RNAs, we considered various 
mRNA controls, which are not expected to bind to these proteins, including Oct4, Nanog, 
Stat3, and Suz12. These mRNAs were selected as examples because they are expressed in 
ES cells, although many mRNAs show similar results. To account for the possibility that the 
Xist RNA non-specifically binds to any RBP, we evaluated Xist with other RBPs that we did 
not identify as interacting with Xist by RAP-MS (Pum1 and hnRNP-H). To ensure that a 
negative result (i.e. no enrichment for Xist) is meaningful and does not reflect a failed 
immunoprecipitation experiment, we evaluated Neat1-1, which we previously found 
immunoprecipitates with hnRNPH(45). To further evaluate the level of enrichment on other 
lncRNAs, we considered several lncRNAs including Malat1, Firre, and Tug1. These 
lncRNAs were selected as examples because they are well-known and expressed in ES cells, 
although many ES lncRNAs show similar results. 
Immunoprecipitation and RT-qPCR  
Female ES cells were differentiated then crosslinked with UV4k as described above. Pellets 
of 20M cells were lysed and treated with TURBO DNase (Ambion) to destroy DNA by 
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incubation for 10 minutes at 37 ˚C in an Eppendorf Thermomixer C. The lysate was pre-
cleared by incubation with 180 μL of Dynabeads Protein G magnetic beads (Life 
Technologies). Meanwhile, 10 μg  of antibody for immunoprecipitation (SHARP antibody, 
Novus NBP1-82952 or IgG antibody, Cell Signaling 2729S) was coupled to 60 μl Protein G 
magnetic beads. After pre-clearing was completed, the lysate was then mixed with the 
appropriate antibody-coupled Protein G magnetic beads and incubated for 2 hours at 4 ˚C on 
a Hulamixer sample mixer (Life Technologies) for protein capture. After 
immunoprecipitation, beads were washed with a wash buffer of 1× PBS with detergents and 
then captured nucleic acids were eluted by digesting all proteins with 5.6 U proteinase K 
(New England Biolabs). Eluted RNA was purified using the RNA Clean and Concentrator-
5 Kit (Zima Research) and RT-qPCR was performed as described previously(1) to evaluate 
RNA enrichment.  
V5-epitope tagged protein expression 
For V5-tagged protein expression and immunoprecipitation, mouse ES cells were 
electroporated using the Neon transfection system (Invitrogen) with an episomally-
replicating vector (pCAG-GW-V5-Hygro) encoding expression of a C-terminal V5 tagged 
ORF driven by a CAG promoter.  ORFs were obtained from the DNASU plasmid repository 
as Gateway entry clones and inserted into pCAG-GW-V5-Hygro using an LR recombination 
reaction (Invitrogen).  Transfected cells were selected on 125ug/mL Hygromycin B 
(Invitrogen) to generate stably expressing lines.  
siRNA Transfections 
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For siRNA knockdown experiments, 20 nM siRNAs were transfected using the Neon 
transfection system (settings: 1200V, 40ms width, 1 pulse). For each transfection, two 10 μL 
transfections with the same siRNA were carried out in succession using 100,000 cells each, 
mixed, and plated equally between two poly-L-lysine or poly-D-lysine (Sigma) and 0.2% 
gelatin (Sigma)-coated #1.5 coverslips placed into wells of a 24-well plate containing 2i 
media. After 48 hours, 2i media was replaced and cells on one coverslip of each pair were 
treated with 2 μg/mL doxycycline (Sigma) for 16hr to induce Xist expression. Coverslips 
were then fixed in Histochoice (Sigma) for 5 min, washed thoroughly in PBS, and dehydrated 
in ethanol for storage until FISH staining. 
For all proteins we used siRNAs pool from Dharmacon (ON-TARGETplus SMARTpool 
siRNAs). For each of these, we tested whether the siRNA successfully reduced the targeted 
mRNA expression by >70%. For SAF-A and SMRT, the siRNAs failed to achieve this level 
of mRNA reduction, so we purchased additional siRNAs (and their associated controls) for 
SAF-A and SMRT from Qiagen and Ambion respectively, and selected siRNAs that 
successfully reduced on-target mRNA levels. siRNA against GFP was purchased from 
Qiagen. For additional independent siRNAs, the siRNAs were purchased as a pool from 
Dharmacon, Qiagen, and Ambion, or as each individual siRNA deconvoluted from the pool 
from Dharmacon and Qiagen (Supplementary Table 2).  
siRNA experiments in female ES cells 
Female ES F1 2-1 cells were similarly transfected. To initiate differentiation and Xist 
expression for these cells, 2i was replaced with MEF media (DMEM, 10% Gemini 
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Benchmark FBS, 1x L-glutamine, 1x NEAA, 1x Pen/Strep; Life Technologies unless 
otherwise indicated) at 12 hours post-transfection. Forty-eight hours after transfection, 1uM 
retinoic acid (Sigma) was administered for 24 hours and cells were fixed as described above. 
For cells not undergoing differentiation, 2i was replaced 12hr and 48hr after transfection. 
Single molecule RNA FISH 
Single molecule RNA Fluorescence in situ hybridization (FISH) experiments were done 
using QuantiGene ViewRNA ISH Cell Assay (Affymetrix) and QuantiGene ViewRNA ISH 
Cell 740 Module (Affymetrix) according to manufacturer’s protocol. Cells fixed on 
coverslips were first permeabilized with Detergent Solution QC at room temperature for 5 
min, and then incubated with desired mixture of probe set (Affymetrix) in Probe Set Diluent 
QF at 40°C for 3 h, followed by incubated with PreAmplifier Mix at 40°C for 30 min, 
Amplifier Mix at 40°C for 30 min, and Label Probe Mix at 40°C for 30 min sequentially. 
For DAPI staining, coverslips were incubated in 30 nM DAPI in PBS at room temperature 
for 15-20 min. Probe set and conjugated fluorophore for FISH were TYPE 1-XIST (550 nm), 
TYPE 4-GPC4, RBMX, SMC1A, MECP2 (488 nm), TYPE 10-ATRX (740 nm), and TYPE 
6-EED1, SHARP, LBR, SAFA, RBM15, MYEF2, PTBP1, HNRNPC, HNRNPM, CELF1, 
RALY, HDAC3, NCOR2, MID1, PIR (650 nm). 
Immunofluorescence and RNA FISH 
For immunofluorescence (IF), cells were fixed on coverslips and permeabilized with 0.1% 
Triton-X in PBS at room temperature for 10 min, and blocked with 5% normal goat serum 
in PBS at room temperature for 10 min. Cells were then incubated with primary antibodies 
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at room temperature for 1 h, followed by incubating with secondary antibodies at room 
temperature for 1 h. The samples were then processed using the RNA FISH protocol, as 
described above. Primary antibodies and the dilution used for IF were anti-RNA polymerase 
II CTD repeat YSPTSPS (phospho S2) (Abcam; ab5095) (1:100), anti-Nanog (Abcam; 
ab80892) (1:100), and anti-EZH2 (Active Motif; 39933) (1:100). Secondary antibodies and 
the dilution used for IF were Alexa Fluor® 405 goat anti-rabbit IgG (H+L) (Life Technology; 
1575534) (1:100) and Alexa Fluor® 488 F(ab’)2 fragment of goat anti-rabbit IgG (H+L) 
(Life Technology; 1618692) (1:100). 
Microscopic Imaging 
FISH and IF/FISH samples were imaged using a Leica DMI 6000 Deconvolution 
Microscope with the Leica HC PL APO 63x/1.30 GLYC CORR CS2 objective. Samples 
stained with TYPE 10-ATRX (740 nm) were imaged using Nikon Ti Eclipse with the Nikon 
CFI Plan Apochromat λ DM 60x/1.40 oil objective. Images were projected with maximum 
projection (3 μm; step size, 0.5 μm). 
X-chromosome Silencing Assay 
Cells were stained for Xist RNA, Gpc4 mRNA, Atrx mRNA and siRNA-targeted mRNA by 
FISH and imaged. In addition, in some siScramble and siSHARP samples, we used probes 
against Rbm15, Mecp2, Smc1a, Mid1 or Pir mRNA. Images were then analyzed using 
Matlab R2013b (described below). Cells were selected if the copy number of the targeted 
mRNA was less than 30% of the level of the no siRNA treated cells and if they induced Xist 
expression. Within these cells, the copy number of Gpc4 mRNA and Atrx mRNA were 
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quantified using a peak finding method (described below) and compared across conditions. 
We quantified mRNA levels for 50 individual cells. We also evaluated Xist expression in 
siRNA-treated cells, and observed no difference in the percentage of cells that induced Xist 
expression in any of the siRNA conditions relative to untreated cells.  
Quantifying mRNAs by single molecule FISH 
All image analysis was carried out using Matlab (version R2013b) utilizing built-in functions 
from the Image Processing toolbox. Images were first filtered using a two-dimensional 
median filter to remove background. Cell boundaries were outlined manually, guided by 
DAPI staining, to create a binary mask and applied to the various channels from the same 
field of view. Top-hat morphological filtering, a background subtraction method that 
enhances the individual focal spots, was applied to the images(46). The spots were then 
identified using a 2D peak finding algorithm that identifies local maximal signals within the 
cell. Once regional maxima were identified, the number of spots was counted for each cell.  
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C h a p t e r  3  
SHARP IS REQUIRED FOR XIST-MEDIATED EXCLUSION OF RNA 
POLYMERASE II 
The work was first published as: 
McHugh, Colleen A., et al. "The Xist lncRNA directly interacts with SHARP to silence 
transcription through HDAC3." Nature 521.7551 (2015): 232. 
3.1    SHARP/SMRT/HDAC3 Complex is Required for Xist-mediated Exclusion of 
RNA Polymerase II 
Xist-mediated transcriptional silencing involves several distinct roles, including (i) initial 
localization to sites on the X-chromosome(1, 2), (ii) establishment of the initial silenced 
compartment – an Xist-coated nuclear domain from which RNA PolII is excluded(3), and 
(iii) repositioning of actively transcribed genes into the RNA PolII-excluded nuclear 
compartment(3, 4). To determine the proteins that are directly responsible for establishing 
the initial silenced compartment on the X-chromosome, we explored whether SHARP or 
LBR might be required for the exclusion of RNA PolII from the Xist-coated region. We 
excluded SAF-A because we observed a diffuse Xist localization pattern in the nucleus upon 
knock down of SAF-A, but not in any other sample, consistent with the previous observation 
that SAF-A is required for Xist localization to chromatin(5). 
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To identify the proteins required for RNA PolII exclusion, we measured co-localization in 
single cells using RNA FISH for Xist and immunofluorescence for PolII upon Xist induction. 
In wild-type cells after 16 hours of Xist induction, we observed a depletion of RNA PolII 
over the Xist-coated territory (Methods, Figure 3.1a). We observed a similar depletion in 
the negative controls and upon knock down of EED (Figure 3.1a, b). Similarly, knock down 
of LBR did not alter the exclusion of PolII from the Xist-coated region (Figure 3.1b). In 
contrast, upon knock down of SHARP, we observed higher levels of PolII over the Xist-
coated territory relative to the control samples (Figure 3.1b). We note that the effects on 
transcriptional silencing and PolII exclusion are robust, being seen with two independent 
siRNA pools (Figure 3.1d).  
Together, these results demonstrate that SHARP is required to exclude RNA PolII on the 
inactive X-chromosome and may be required for creating the initial silenced compartment 
upon Xist localization(4). While LBR is not required for initial PolII exclusion on the X-
chromosome, it is likely to play an alternative role during the initiation of Xist-mediated 
transcriptional silencing, such as repositioning genes into this PolII excluded compartment(2, 
3). 
Having identified SHARP as the direct Xist-interacting protein that is required for excluding 
RNA PolII on the X-chromosome, we sought to determine how it might carry out this role. 
SHARP is a direct RNA binding protein(6, 7) that was identified based on its interaction with 
the SMRT co-repressor complex(7, 8), which is required for activating the deacetylation and 
transcriptional silencing activity of HDAC3 in vivo (9, 10). Based on these previous 
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observations, we hypothesized that Xist-mediated transcriptional silencing through 
SHARP would occur through SMRT and the silencing function of HDAC3.  
To test this hypothesis, we knocked down either SMRT or HDAC3 and measured the 
expression of X-linked genes before and after Xist induction. Knock down of SMRT or 
HDAC3 abrogated silencing of X-linked genes upon induction of Xist expression (Figure 
2.2b, g). To determine whether this effect is similar to the effect produced by knock down of 
SHARP or a distinct defect in transcriptional silencing, we tested whether HDAC3, the 
silencing protein in this complex(10, 11), is required for the exclusion of RNA PolII from 
the Xist-coated territory. We found that knock down of HDAC3 eliminated the exclusion of 
RNA PolII from the Xist-coated compartment to a similar degree to that seen for knock down 
of SHARP (Figure 3.1a-d).  
Together, these results suggest that SHARP silences transcription through the HDAC3 
silencing protein. This role for HDAC3 in Xist-mediated silencing would explain the long-
standing observation of global hypoacetylation on the entire X-chromosome as one of the 
very first events that occur upon initiation of XCI(4, 12). 
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Figure 3.1 SHARP is required for exclusion of PolII from the Xist-coated territory. 
(a) Individual male ES cells labelled with Xist (red), PolII (green), and DAPI (blue) across 
different siRNA conditions (rows). Quantification of fluorescence intensity of PolII within 
Xist territory normalized to control siRNA levels for (b) male ES cells after 16 hours of 
doxycycline treatment and (c) female ES cells after 1 day of retinoic acid induced 
differentiation. (d) Images of individual cells that are labeled with Xist (red), RNA 
Polymerase II (green), and DAPI (blue) across different siRNA conditions (rows) in female 
ES cells after 24 hours of retinoic acid treatment. The dashed white region represents the 
outlined Xist coated territory. Error bars: standard error across 50 cells from one 
experiment. NS: not significant, **** p-value<0.001 relative to siControl by unpaired two-
sample t-test. ΔA: Genetic deletion of A-repeat. Scale bars, 5 micrometers. 
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3.2    SHARP is Required for Xist-mediated Recruitment of PRC2 
One of the features of the initiation of X-chromosome inactivation is the recruitment of the 
PRC2 complex across the X-chromosome in an Xist-dependent manner(13-15). While PRC2 
is not required for the initiation of XCI(16, 17) (Figure 2.2b, g), it or its associated 
H3K27me3 repressive chromatin modifications may be involved in establishing an 
epigenetically silenced state(18, 19). Yet how Xist recruits the PRC2 complex across the X-
chromosome is unknown.  
Since we failed to identify any PRC2 components in our RAP-MS data, we reasoned that 
PRC2 recruitment across the X-chromosome might occur through one of the other identified 
direct interacting proteins. Specifically, we hypothesized that SHARP might be required to 
recruit PRC2 to the X-chromosome for three main reasons: (i) SHARP is required for RNA 
PolII exclusion, which has been shown to be sufficient to trigger PRC2 recruitment in other 
contexts(20); (ii) Previous studies have shown that the PRC2 complex can interact with 
various HDAC complexes(21) or may be recruited through HDAC mediated compaction of 
chromatin(22); (iii) SHARP has been shown to interact in vitro with RbAp48(7), a 
component of several chromatin regulatory complexes including the PRC2(23, 24) and 
HDAC3 complexes(25, 26). 
To test this hypothesis, we looked at PRC2 recruitment to the Xist-coated territory. In wild-
type cells, we observe a strong enrichment of EZH2, a component of PRC2, over the Xist-
coated territory after 16 hours of induction (Figure 3.2a). Upon knock down of EED, a 
distinct component of the PRC2 complex that is required for its proper localization to 
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chromatin(23, 24), we observe no enrichment of EZH2 over the Xist cloud at this same 
time point (Figure 3.2a). Similarly, upon knock down of SHARP, we identified a loss of 
EZH2 over the Xist coated territory, of comparable magnitude to that observed in the absence 
of EED (Figure 3.2a). Conversely, upon knock down of LBR, we observed a strong 
enrichment of EZH2 over the Xist coated territory, of comparable magnitude to the levels of 
recruitment in wild-type conditions (Figure 3.2b). To determine whether HDAC3 is required 
for PRC2 recruitment, we knocked down HDAC3 and observed a loss of PRC2 recruitment 
(Figure 3.2a), of comparable magnitude to that observed upon loss of SHARP (Figure 3.2b). 
Together, these results argue that PRC2 recruitment across the X-chromosome is dependent 
on the Xist interaction with SHARP and the activity of HDAC3. Whether this occurs through 
an interaction with HDAC3 (direct recruitment) or due to the HDAC3-induced silenced 
transcription state, chromatin modifications, or compact chromatin structure (indirect 
recruitment) remains unclear. We note that our results are in contrast to previous reports that 
PRC2 is recruited to the X-chromosome through a direct interaction between Ezh2 and the 
A-repeat of Xist(15). Instead, our results are consistent with reports that the deletion of the 
A-repeat, unlike knock down of SHARP or HDAC3, has no significant effect on PRC2 
recruitment(13, 27) (Figure 3.2b). 
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Figure 3.2. SHARP is required for PRC2 recruitment across the Xist-coated territory. 
(a) Images of individual male ES cells that are labeled with Xist (red), Ezh2 (green) and 
DAPI (blue) across different siRNA conditions (rows). Quantification of the level of Ezh2 
within the defined Xist territory normalized to the levels in the control siRNA sample for (b) 
male ES cells and (c) differentiating female ES cells. (d) . Images of individual cells that are 
labeled with Xist (red), Ezh2 (green), and DAPI (blue) across different siRNA conditions 
(rows) in female ES cells after 24 hours of differentiation. Error bars: standard error of the 
mean across 50 cells from one experiment. NS: not significant, ***, p-value<0.005, **** p-
value<0.001 relative to siControl by an unpaired two-sample t-test. Scale bars, 5 
micrometers. The dashed white region represents the outlined Xist coated territory. 
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Methods 
Only the methods that have not yet been described in previous Chapters are listed 
Ezh2 Recruitment and PolII Exclusion 
Cells were stained for Xist RNA and the siRNA-targeted mRNA (FISH) along with Ezh2 or 
PolII (IF) as described above. For image acquisition, the exposure time for each individual 
channel was kept the same across all samples. Images were then analyzed and selected for 
XIST-induced and cells showing knock down of the target mRNA, as described above. 
Specifically, the nuclei of individual cells were identified manually using the DAPI staining. 
We identified the Xist cloud by using an intensity-based threshold to partition the image 
within the nucleus and find contiguous 2-dimensional regions of high intensity. The 
threshold was determined based on Otsu method as previously described50, which splits the 
image into 2 bins – high and low – and identifies a threshold that minimizes the variance 
within the partition. This creates a binary mask on the image. We visually confirmed that this 
binary mask accurately reflected the Xist cloud. We then applied this binary mask to all other 
images in that field of view (PolII or Ezh2) for all images. We then quantified the intensity 
of fluorescence signal by taking the average intensity of all the pixels within the region (i.e. 
PolII or Ezh2, respectively). We computed this average intensity (1 number per cell) across 
all conditions and compared them using a 2-same unpaired t-test relative to the scramble 
sample across 50 single cells.  
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C h a p t e r  4  
LBR IS REQUIRED FOR XIST SPREADING TO ACTIVELY 
TRANSCRIBED GENES ACROSS THE X-CHROMOSOME 
The work was first published as: 
Chen, Chun-Kan, et al. "Xist recruits the X chromosome to the nuclear lamina to enable 
chromosome-wide silencing." Science 354.6311 (2016): 468-472. 
4.1    LBR Requires its Arginine-Serine (RS) Motif to Interact with Xist 
Although the 3-dimensional structure of the nucleus is dynamically organized in different 
cellular conditions (1-3), it is generally unclear whether these structural changes reflect 
distinct regulatory states or whether they lead to changes in gene regulation (2, 4, 5). X 
chromosome inactivation (XCI) represents an ideal model to study the relationship between 
dynamic 3-dimensional nuclear organization and gene regulation because initiation of XCI 
entails chromosome-wide transcriptional silencing (6, 7) and large scale remodeling of the 
3-dimensional structure of the X chromosome (8-12).  
The Xist lncRNA initiates XCI by spreading across the future inactive X chromosome and 
excluding RNA Polymerase II (PolII) to silence chromosome-wide transcription (7, 13-15). 
Xist initially localizes to genomic DNA regions on the X chromosome that are not actively 
transcribed (16-19) before spreading to actively transcribed genes (17). Deletion of a highly 
conserved region of Xist that is required for transcriptional silencing, called the A-repeat 
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region (20), leads to a defect in Xist spreading to actively transcribed genes on the X 
chromosome (17) and spatial exclusion of active genes from the Xist-coated nuclear 
compartment (21). While these results suggest a role for Xist in remodeling the 3-
dimensional structure of the X chromosome, whether these structural changes are required 
for, or merely a consequence of, transcriptional silencing mediated by the A-repeat of Xist 
remains unclear (17, 22). 
Addressing this question requires understanding the molecular components involved in Xist-
mediated transcriptional silencing. Recently, we and others identified the proteins that 
interact with Xist using mass spectrometry (23-25). One of these proteins is the Lamin B 
Receptor (LBR) (23, 25), a transmembrane protein that is anchored in the inner nuclear 
membrane (26), interacts with Lamin B (27, 28), and is required for anchoring chromatin to 
the nuclear lamina (27) – a nuclear compartment that helps shape the 3-dimensional structure 
of DNA (2, 3, 29) and is enriched for silencing proteins (2, 3, 30, 31). Based on these 
observations, along with the observation that induction of XCI leads to recruitment of the 
inactive X-chromosome to the nuclear lamina (11, 12), we hypothesized that the Xist-LBR 
interaction might be important both for shaping nuclear organization and regulating gene 
expression during XCI. 
To determine whether LBR-mediated silencing is due to its interaction with Xist, we sought 
to disrupt its RNA binding region. However, among the 10 Xist-interacting proteins that we 
previously identified (11), LBR is the only protein that does not contain a canonical RNA 
binding domain. We hypothesized that the Arginine-Serine (RS) motif of LBR might be 
required for interacting with Xist because the RS motif is present within a class of mRNA 
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binding proteins involved in splicing (SR proteins) (31–33), is overrepresented in RNA 
binding proteins that lack canonical RNA binding domains (34), and the RS motif of LBR 
was previously shown to interact with RNA in vitro (35). To test this, we generated a 
truncated LBR protein containing a deletion of the RS motif (∆RS-LBR, Figure 4.1a, 
Methods). As a control, we also deleted seven of the eight transmembrane domains in LBR 
(∆TM-LBR, Figure 4.1a, Methods). Consistent with previous observations (32), we find 
that both ∆RS-LBR and ∆TM-LBR localize properly in the nuclear envelope (Figure 4.1b). 
Importantly, ∆RS-LBR did not interact with Xist (~97% reduction relative to wild-type 
levels, Figure 4.1c, Methods) and failed to rescue the silencing defect upon knock down of 
LBR (Figure 4.1d). In contrast, ∆TM-LBR did not impact Xist binding (Figure 4.1c) and 
was able to rescue the silencing defect upon knock down of LBR (Figure 4.1d).  
To ensure that ∆RS-LBR fails to silence X chromosome genes because of its RNA binding 
ability and specifically its interaction with Xist, we tested whether artificially tethering ∆RS-
LBR to the Xist RNA can re-establish Xist-mediated silencing. To do this, we fused 3 copies 
of the viral BoxB RNA aptamer, which binds tightly to the viral λN coat protein (33-35), to 
the 3’ end of the endogenous Xist RNA (Xist-BoxB, Figure 4.1e, Methods) and ensured 
that Xist-BoxB still silences X chromosome genes (Figure 4.1f). Expression of ∆RS-LBR-
λN in Xist-BoxB cells rescued the silencing defect observed upon LBR knock down (Figure 
4.1g). Together, these results demonstrate that the Xist-LBR interaction is required for Xist-
mediated transcriptional silencing (Figure 4.1h). 
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Figure 4.1. LBR requires its RS motif to interact with Xist and silence transcription. 
(a) The domain structure of the LBR protein highlighting the Tudor domain (red), RS motif 
(blue), and 8 transmembrane domains (gray). The regions deleted in ΔRS-LBR (amino acids 
71-90) and ΔTM-LBR (amino acids 237-615). (b) Images of individual cell stained with 
endogenous LMNB1 (green) and FLAG-tag (red) in cells transfected with empty vector 
(WT) or λN-3xFLAG tagged ∆TM-LBR, ∆RS-LBR, or full-length LBR. The λN-3xFLAG 
tagged proteins colocalize with endogenous LMNB1 demonstrating that these mutants 
localize properly in the nuclear envelope. Scale bars: 5 micrometers. (c) Xist RNA levels 
measured by RT-qPCR after immunoprecipitation of a 3x-FLAG tagged LBR mutants 
relative to the input in cells expressing full-length LBR (WT), ΔRS-LBR, or ΔTM-LBR. 
Error bars represent the standard error from three independent IP experiments. NS: not 
significantly different from the input; **** represents values significantly different from the 
input with a p-value<0.001 based on an unpaired two-sample t-test. (d) Relative Atrx mRNA 
expression upon knockdown of the endogenous LBR and expression of full length LBR 
(WT), ΔTM-LBR, or ΔRS-LBR. (e) A schematic of the interaction between λN-fusion 
protein and Xist containing 3 copies of the BoxB RNA aptamer. (f) Quantification of the 
copy number of Atrx mRNA prior to Xist-BoxB induction (-Dox) and after Xist-BoxB 
induction (+Dox). (g) Relative Atrx mRNA expression in Xist-BoxB cells after knockdown 
of the endogenous LBR and expression of GFP-λN (control), LBR-λN, or ΔRS-LBR-λN. (h) 
A schematic of the nuclear lamina and the interaction between LBR and Xist. Error bars: 
SEM across 50 individual cells. NS: not significant, **** p-value<0.001 relative to wild type 
cells (d, f), or cells transfected with GFP-λN (g) by an unpaired two-sample t-test. 
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4.2    LBR Binds to Precise Regions of the Xist RNA that are Required for Silencing 
To determine where LBR binds to Xist, we UV-crosslinked RNA-protein complexes in cells, 
digested RNA into short fragments, immunoprecipitated LBR, gel extracted crosslinked 
RNA-protein complexes, and sequenced the Xist RNA (CLIP (41–43), Methods). We 
identified 3 discrete LBR binding sites (LBS) that are spread across >10,000 nucleotides of 
the Xist RNA (Figure 4.2a). These LBR binding sites are distinct from the binding sites of 
other Xist interacting proteins, including SHARP and PTBP1 (Figure 4.2a). Interestingly, 
one of these LBR binding sites (LBS-1) is present within the ~900 nucleotide region of Xist 
that was previously shown to be required for Xist-mediated silencing (∆A-repeat region) (20) 
(Figure 4.2a).  
We tested LBR binding within a previously generated ∆A-repeat cell line (20) and found that 
LBR binding is lost across the entire Xist RNA (Figure 4.2b). Because SHARP also binds 
within the ∆A-repeat region (24, 44) (Figure 4.2a) and its binding is also disrupted in ∆A-
Xist (24) (Figure 4.2b), we generated a mutant Xist that precisely deletes the LBR binding 
site, but not the SHARP binding site, that overlaps the ∆A-repeat region (∆LBS, Figure 
4.2a). In ∆LBS-Xist, LBR binding was lost across the entire Xist RNA without impacting 
SHARP binding (Figure 4.2b). Importantly, ∆LBS-Xist fails to silence X chromosome 
transcription to a similar level as observed in the ∆A-Xist (Figure 4.2c).  
To ensure that the observed silencing defect in ∆LBS-Xist cells is due to LBR binding alone 
and not due to disruption of another unknown protein interaction, we tested whether we could 
rescue the observed silencing defect by re-establishing the ∆LBS-LBR interaction. To do 
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this, we generated an endogenous ∆LBS-BoxB Xist RNA (Methods) and confirmed that 
expression of LBR-λN fusion protein, but not LBR fused to a different RNA binding domain 
(MS2-coat protein(45)), was able to rescue the silencing defect observed in ∆LBS-BoxB 
cells (Figure 4.2d, Methods). In contrast, expression of other silencing proteins fused to λN, 
such as SHARP and EED, did not rescue the observed silencing defect (Figure 4.2d). 
Together, these results demonstrate that the LBR binding site that overlaps the ∆A-repeat 
region of Xist is required for silencing.  
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Figure 4.2. LBR binds to precise regions of the Xist RNA that are required for silencing. 
(a) CLIP data plotted across the Xist RNA for LBR, SHARP, and PTBP1 proteins. The 
values represent fold-enrichment at each position on Xist normalized to a size-matched input 
RNA control. Input represents the total RNA control for the LBR sample. Bottom: A 
schematic of the annotated repeat regions on the Xist RNA (WT) and the locations of the 
deleted regions in ΔA (nucleotides 1-937) and ΔLBS (nucleotides 998-1782). (b) Xist RNA 
enrichment level measured by RT-qPCR after immunoprecipitation of endogenous LBR or 
SHARP in wild-type, ΔA, or ΔLBS cells. Error bars: SEM from four independent IP 
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experiments. (c) Relative Atrx mRNA expression in wild-type, ΔA, or ΔLBS-Xist cells. 
(d) Expression of ΔLBS-Xist with a 3x-BoxB fusion (ΔLBS-BoxB) along with expression 
of GFP-λN (control), EED-λN, SHARP-λN, or LBR-λN. As an additional control, we 
expressed LBR fused with the bacteriophage MS2 Coat Protein (LBR-MCP). Error bars: 
SEM across 50 individual cells. NS: not significant, *** p-value<0.005, **** p-value<0.001 
relative to wild type cells (b, c), or cells transfected with GFP-λN (d) by an unpaired two-
sample t-test. 
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4.3    LBR is Required for Recruitment of the Xist-coated Compartment to Nuclear 
Lamina 
Because induction of XCI is known to lead to recruitment of the inactive X chromosome to 
the nuclear lamina (11, 12, 46), we hypothesized that the Xist-LBR interaction might be 
required for mediating these structural changes. To test this, we measured the distance 
between the Xist-coated nuclear compartment and Lamin B1 in the nucleus using RNA FISH 
and immunofluorescence (Figure 4.3a, Methods). Specifically, we computed the minimum 
distance between the edge of the Xist compartment and Lamin B1. To account for differences 
in nuclear size, we normalized the measured distance by the nuclear radius.  
Upon Xist induction in wild-type cells, we find that the Xist compartment overlaps Lamin 
B1 signal in the vast majority of wild-type cells (~88%, Figure 4.3). In contrast, in ∆LBS-
Xist cells, which disrupt the Xist-LBR interaction, the vast majority of cells (~85%) 
displayed a clear separation between the Xist-coated compartment and Lamin B1 (Figure 
4.3), demonstrating a ~17-fold increase in the distance between the Xist compartment and 
Lamin B1 relative to the distances observed for wild-type Xist. In ∆A-Xist cells, which also 
ablate the Xist-LBR interaction, we observe a comparable distance distribution between Xist 
and Lamin B1 to that observed in the ∆LBS-Xist (Figure 4.3). These results demonstrate 
that recruitment of the inactive X chromosome to the nuclear lamina is an active process that 
is directly mediated by the Xist RNA through a direct interaction with LBR.  
Having demonstrated that the Xist-LBR interaction is important for recruitment of the X 
chromosome to the nuclear lamina, we sought to explore why LBR is important for Xist-
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mediated transcriptional silencing. One possibility is that recruitment of the X 
chromosome to the nuclear lamina, a nuclear territory enriched for silenced DNA and 
repressive chromatin regulators(36), acts to directly silence transcription. Consistent with 
this notion, recruitment to the lamina has been shown in some cases to be sufficient to silence 
transcription (37, 38). To test this hypothesis, we explored the nuclear lamina association 
upon knock down of SHARP, which we previously showed is required for Xist-mediated 
transcriptional silencing (23, 24, 39, 40). We found that in the absence of SHARP, the Xist-
coated compartment is still localized at the nuclear lamina, demonstrating a comparable 
distance distribution between Xist and Lamin B1 to that observed for wild-type Xist (Figure 
4.3). These results demonstrate that Xist-mediated recruitment of the X chromosome to the 
lamina does not directly lead to transcriptional silencing. 
  
  
82 
 
Figure 4.3. Xist-mediated recruitment of DNA to the nuclear lamina is required for 
transcriptional silencing. (a) Images of Xist (red), Lamin B1 (green) and DAPI (blue) 
across different conditions. Scale bars: 5 micrometers. (b) The cumulative frequency 
distribution of normalized distances between Xist and Lamin B1 across 40 individual cells 
across different conditions. Dashed lines represents a second independent experiment. 
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4.4    LBR is Required for Xist Spreading to Actively Transcribed Genes across the 
X-Chromosome 
The A-repeat region of Xist was previously shown to lead to an Xist spreading defect such 
that genes that are actively transcribed prior to initiation of XCI are no longer repositioned 
into the Xist compartment (17, 21). Because LBR binds within the previously deleted A-
repeat region of Xist (∆A), we hypothesized that LBR-mediated recruitment of the X 
chromosome to the nuclear lamina might act to reposition actively transcribed genes into the 
Xist-silenced compartment. 
To test this hypothesis, we explored the localization of Xist across the X chromosome using 
RAP-DNA. RAP-DNA enables comprehensive mapping of Xist to all genomic DNA sites – 
including active and inactive genes as well as intergenic regions. We confirmed that Xist 
RNA localization is depleted over large regions that contain actively transcribed genes, but 
not inactive genes, in ∆A-Xist expressing cells(17). In ∆LBS-Xist cells or upon knock down 
of LBR, we observed a comparable Xist localization defect as in ∆A-Xist, with strong 
depletion of Xist observed across all actively transcribed genes(17) (Figure 4.4a, b). To 
ensure that this result is specific to LBR, we knocked down SHARP, a protein that is also 
required for silencing and that also interact with the A-repeat region of Xist. Upon knock 
down of SHARP, we did not observe an Xist RNA localization defect; instead Xist 
localization was comparable to that observed in wild-type conditions (Figure 4.4b). 
To determine whether this spreading defect is due to a failure to reposition actively 
transcribed genes into the Xist-coated compartment, we measured the position of active 
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genes relative to the Xist coated compartment using RNA FISH (Figure 4.4c, Methods). 
We labeled the genomic locus of an actively transcribed X chromosome gene (Gpc4) using 
probes against its intronic region and calculated the distance to the Xist compartment 
(Methods). As a control, we measured the distance between the genomic locus of an 
autosomal gene (Notch2), which should always be excluded from the Xist compartment. In 
∆A cells, the distance between the Xist compartment and the Gpc4, Mecp2, or Pgk1 loci was 
comparable to the distance between Xist and the autosomal locus (Figure 4.4d, e). Similarly, 
in ∆LBS cells or upon knock down of LBR, we observed a comparably large distance 
between the Gpc4, Mecp2, or Pgk1 loci and the Xist compartment (Figure 4.4d, e). In 
contrast, upon knockdown of SHARP, we found that the Gpc4 locus overlapped with the 
Xist compartment in the vast majority (~80%) of all cells (Figure 4.4d, e) displaying a 
comparable frequency of overlap to that observed for the Xist genomic locus itself. 
Together, these results demonstrate that the Xist-LBR interaction is required for Xist 
spreading to actively transcribed DNA loci. Because Xist can still spread to active genes 
upon knock down of SHARP, this argues that spreading to active genes occurs independently 
of RNA PolII exclusion and that both roles – spreading and RNA PolII exclusion – are 
required for silencing. As both roles are mediated by the A-repeat, this would explain why 
the A-repeat mutant fails to display an RNA PolII exclusion defect, as observed upon knock 
down of SHARP, because in the absence of Xist spreading to active genes, SHARP cannot 
localize to and exclude PolII from these active genes. 
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Fig. 4.4. LBR is Required for Xist Spreading to Actively Transcribed Genes across the 
X-Chromosome. (a) Xist RNA localization as measured by RAP-DNA for wild type (top), 
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ΔLBS-Xist (middle), and the smoothed fold change (bottom) across a region of the X 
chromosome containing active (red) and inactive (blue) genes. Dashed line: average Xist 
enrichment in wild type cells. (b) Aggregate Xist enrichment relative to the genomic 
locations of highly active genes (dark red, RPKM > 5), all active genes (red, RPKM >1), and 
inactive genes (blue) on the X-chromosome for ΔLBS and SHARP knockdown cells 
compared to wild type cells. Shaded areas represent 95% confidence interval. (c) Images of 
Xist (red), Gpc4 locus (green) and DAPI (blue) across different cell lines (rows) after Xist 
induction for 1 or 16 hours. Scale bars: 5 micrometers. (d) The median distance from Gpc4 
locus to the Xist-compartment after Xist induction for 1, 3, 6, and 16 hours. Error bars 
represent the standard error of the median across 50 individual cells. ** p-value<0.01 relative 
to 1-hour induction by an unpaired two-sample t-test. (e) The median distance from the 
Mecp2 and Pgk1 locus to the Xist compartment after Xist induction for 16 hours across 
different conditions. Error bars represent the standard error of the median across 50 
individual cells. ** p-value<0.01, *** p-value<0.005 relative to siSHARP by an unpaired 
two-sample t-test. (F) A model for how Xist-mediated recruitment to the nuclear lamina 
enables spreading to active genes and transcriptional silencing on the X chromosome.  
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4.5    Recruitment to the Nuclear Lamina Enables Xist Spreading and Silencing of 
Active Genes 
Having established that LBR is required for Xist-mediated transcriptional silencing, 
recruitment of the Xist-coated compartment to the nuclear lamina, and for Xist RNA 
spreading to actively transcribed genes, we hypothesized that Xist-mediated recruitment of 
DNA to the nuclear lamina enables Xist to spread to active genes and silence transcription. 
We reasoned that if we recruit Xist to the nuclear lamina, independent of LBR, then Xist will 
spread to active genes and rescue Xist-mediated transcriptional silencing (Figure 4.5a). To 
test this, we used our ∆LBS-BoxB Xist, which fails to interact with LBR, to create an 
interaction between Xist and other components of the nuclear lamina that on their own do 
not impact X chromosome silencing in normal conditions. Specifically, we created a fusion 
between Lamin B1 and λN and confirmed that expression of this fusion protein in ∆LBS-
BoxB Xist cells led to recruitment of the Xist-compartment to the nuclear lamina using RNA 
FISH and immunofluorescence of Lamin B1 (Figure 4.5b-d). 
Having synthetically recruited Xist to the nuclear lamina, we tested whether Xist can spread 
to actively transcribed genes using RAP-DNA. Indeed, tethering Xist to the nuclear lamina 
is sufficient to enable Xist to spread to active genes, with Xist localizing to active genes and 
inactive genes at comparable levels, similar to that observed in wild-type conditions (Figure 
4.5e). Consistent with a functional requirement for Xist spreading across active genes to 
enable X chromosome silencing, we find that tethering Xist to the nuclear lamina also rescues 
the Xist silencing defect observed in ∆LBS cells to the same extent as that observed after 
rescuing directly with LBR-λN (Figure 4.5f). 
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Together, these results demonstrate that Xist-mediated recruitment of the X chromosome 
to the nuclear lamina leads to Xist spreading to active genes, and through this enables Xist-
mediated transcriptional silencing. 
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Figure 4.5. Recruitment to the nuclear lamina enables Xist spreading and silencing of 
active genes. (a) A schematic illustrating the tethering of ΔLBS-BoxB to the nuclear lamina 
using the LaminB1-λN fusion protein. (b) Images of individual cell stained with endogenous 
LBR (green) and FLAG-tag (red) in cells transfected with empty vector (WT) or λN-
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3xFLAG tagged LMNB1. The λN-3xFLAG tagged LMNB1 localizes properly in the 
nuclear envelope and colocalizes with endogenous LBR. Scale bars: 5 micrometers. (c) 
Images of Xist (red), Lamin B1 (green) and DAPI (blue) across different conditions. Scale 
bars: 5 micrometers. (d) The cumulative frequency distribution of normalized distances 
between Xist and Lamin B1 across 40 individual cells across different conditions. Dashed 
lines represent a second independent experiment. (e) Aggregate Xist enrichment relative to 
the genomic locations of highly active genes (dark red, RPKM > 5), all active genes (red, 
RPKM >1), and inactive genes (blue) on the X-chromosome ΔLBS-BoxB + LMNB1-λN 
cells compared to wild type cells. Shaded areas represent 95% confidence interval. (f) Three 
independent replicates (two for LMNB1-λN) showing the copy number of Atrx mRNA 
molecules after induction of Xist normalized to the number of the mRNA molecules prior to 
Xist induction in cells expressing ΔLBS-BoxB Xist transfecting with LBR-MCP, LBR-λN, 
λN-LMNB1 or LMNB1-λN fusion protein. Error bars represent the standard error across 50 
individual cells. NS: not significantly different from 1; **** represents values significantly 
different from 1 with a p-value<0.0001 based on a one-sample t-test. 
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Methods 
Only the methods that have not yet been described in previous Chapters are listed 
LBR knockout female ES cells  
We generated an LBR knockout in female ES cells using the CRISPR-Cas9 system. 
Specifically, we co-transfected a construct expressing Cas9 driven by a pCAG promoter 
and a pool of sgRNAs targeting an upstream and downstream region of LBR locus to 
delete the entire genomic locus (upstream sgRNA sequences: 
GGCGATGATTCAAAAGGTCG, AGCGCCGGCGATGATTCAAA, 
GGGCTCCGGCCTGGGCCTGC, TGAAATAAGAGAATGTTATA; downstream 
sgRNA sequences: TTTAACCTGTTTTTAGGTCT, AGGCTGTCTGGTCAGAATCC, 
CGAAGAAACCTCCCAGTCAC, CATTTTTGGTTTATTCATGG). We then picked 
single colonies from transfected cells and verified LBR knockout using PCR and Sanger 
sequenced successful homozygous knockout lines with primers flanking deletion sites. We 
confirmed that this deletion leads to a complete loss of function of LBR using RNA FISH 
and immunofluorescence of the protein. 
Integrating the BoxB aptamer sequence into Xist  
We knocked in 3 copies of the viral BoxB RNA aptamer, which binds tightly to the viral 
λN coat protein (38–40), into nucleotide 16,523 of the endogenous Xist RNA in pSM33 ES 
cell line using CRISPR-mediated homologous recombination. Specifically, we co-
transfected a construct expressing Cas9 driven by a pCAG promoter, a sgRNA targeting 
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the 3’ region of the Xist locus (sgRNA sequence: CCTCATCCTCATGTCTTCTC), and 
a single strand DNA ultramer (IDT) containing a 3x-BoxB sequence 
(GGGCCCTGAAGAAGGGCCCATGGGCCCTGAAGAAGGGCCCATAGGGCCCTG
AAGAAGGGCCC; underlined nucleotides denote the BoxB sequence) flanked with 70 
nucleotides of upstream and downstream homologous sequence of the insertion site. We 
then picked single colonies from transfected cells and verified BoxB integration using PCR 
and Sanger sequenced successful integration lines with primers flanking the integration site 
and confirmed correct insertion. We ensured that the Xist-BoxB was still able to silence the 
X chromosome by expressing it and measuring transcriptional silencing of Atrx. 
UV crosslinking 
Cells were washed once with PBS and then crosslinked on ice using 0.4 Joules/cm2 (UV4k) 
of UV at 254 nm in a Spectrolinker UV Crosslinker. Cells were then scraped from culture 
dishes, washed once with PBS, pelleted by centrifugation at 1500 × g for 4 minutes, and flash 
frozen in liquid nitrogen for storage at – 80 ˚C.  
Immunoprecipitation and RT-qPCR  
Mouse ES cells were induced then crosslinked with UV4k as described above. Pellets of 
20M cells were lysed and treated with TURBO DNase (Ambion) and incubated for 10 
minutes at 37 ˚C in an Eppendorf Thermomixer C to digest genomic DNA. The lysate was 
pre-cleared by incubation with 180 μL of Dynabeads Protein G magnetic beads (Life 
Technologies). Meanwhile, 10 μg of antibody for immunoprecipitation was coupled to 75 μl 
Protein G magnetic beads. After pre-clearing was completed, the lysate was then mixed with 
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the appropriate antibody-coupled Protein G magnetic beads and incubated overnight at 4 
˚C on a Hulamixer sample mixer (Life Technologies) for protein capture. After 
immunoprecipitation, beads were washed with a wash buffer of 1× PBS with detergents and 
then captured nucleic acids were eluted by digesting all proteins with 5.6 U proteinase K 
(New England Biolabs). Eluted RNA was purified using the RNA Clean and Concentrator-
5 Kit (Zymo Research) and RT-qPCR was performed as described previously (7) to evaluate 
RNA enrichment. The antibodies used for immunoprecipitation were anti-FLAG® M2 
(Sigma-Aldrich; F1804) (for ΔTM- and ΔRS-LBR transfected cells), anti-SHARP (Bethyl; 
A301-119A), and customized LBR antibody from GenScript (LBR #4; 540774‐1). 
Crosslinking and Immunoprecipitation (CLIP) analysis 
We crosslinked 6 hour doxycycline-induced pSM33 mouse male ES cells with 0.4 J/cm2 of 
UV254. Cells were lysed and RNA was digested with RNase I to achieve a size range of 
100-500 nucleotides in length. Lysate preparations were precleared by mixing with Protein 
G beads for 1 hr at 4C. For each CLIP sample, target proteins were immunoprecipitated from 
20 million cells with 10 ug of antibody and 75 ul of Protein G beads. The antibodies were 
pre-coupled to the beads for 1 hr at room temperature with mixing before incubating the 
precleared lysate to the beads-antibody overnight at 4C. After the immunoprecipitation, the 
beads were washed four times with High salt wash buffer (50 mM Tris-HCl pH 7.4, 1 M 
NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate) and four times with 
Wash buffer (20 mM Tris-HCl pH 7.4, 10 mM MgCl2, 0.2% Tween-20). RNAs were then 
eluted with NLS elution buffer (20 mM Tris-HCl pH 7.5, 10 mM EDTA, 2% N-
lauroylsacrosine, 2.5 mM TCEP) with 100 mM DTT. Samples were then run through a 
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standard SDS-PAGE gel and transferred to a nitrocellulose membrane, and a region 75 
kDa above the molecular size of the protein of interest was isolated and treated with 
Proteinase K (NEB) followed by phenol/chloroform/isoamyl alcohol (pH 6.5) extraction to 
isolate the RNAs. Extracted RNAs were then purified with RNA Clean & Concentrator™-5 
(Zymo). After a dephosphorylation treatment, the RNA in each sample was ligated to a 
mixture of barcoded adapters in which each adapter had a unique barcode identifier 
according to our Massively Multiplexed RNA Sequencing method (25). After ligation, beads 
were rinsed with 1x PBS and detergents and then 5x PBS and detergents prior to pooling 3-
4 IPs per new tube. The proteins and RNA were then eluted from the Protein G beads with 
6M urea and 40 mM DTT at 60C. Protein-RNA complexes were separated away from free 
RNA and the proteins were then digested with Proteinase K. From the barcoded RNA in each 
pool, we generated Illumina sequencing libraries as previously described(26). 
Input samples: As a control, we sequenced an “input” RNA control for each 
immunoprecipitated protein. To do this, we saved 10% of the total cellular lysate prior to the 
immunoprecipitation step. These samples were then run through an SDS-PAGE gel 
alongside the immunoprecipitated sample and gel extracted from the identical region as the 
protein analyzed. We then made sequencing libraries from these samples as described above. 
Analysis of CLIP Data 
We computed and visualized the enrichment for any RNA region by normalizing the number 
of reads upon immunoprecipitation with a specific protein relative to the number of reads in 
its size-matched input control (input sample). Specifically, we counted the total number of 
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reads overlapping the RNA region in either the immunoprecipitation sample or the input 
control. To account for differences in read coverage between samples, each of these numbers 
was normalized to the total number of reads within the same experiment. This generates a 
normalized score, per region, within each sample. We then computed an enrichment metric 
by taking the ratio of these normalized values (IP/Input).  
We identified protein binding sites on the Xist RNA by identifying regions that were enriched 
relative to the same region in the input control (“differential enrichment”) and also was 
enriched relative to all other regions on the remainder of the Xist RNA (“local enrichment”). 
The differential enrichment accounts for biases in the size-selected input sample that would 
lead to a pile up of reads in specific regions of the RNA, but that do not reflect true protein 
binding sites. In contrast, the local enrichment accounts for cases where a given RNA might 
have higher overall levels of protein binding relative to the input. To compute significant 
enrichment, we computed the differential enrichment as defined above (IP/Input) for each 
window (window size=100 nucleotides). We computed the local enrichment for each region 
by taking the normalized number of reads for each region (IP) and dividing it by the 
normalized number of reads over the entire Xist RNA. To make these rates comparable, we 
divided each number by their respective region length prior to taking the ratio. We then 
generated 1,000 random permutations of the reads in the IP samples and paired input samples 
across the Xist RNA. For each permutation, we computed the differential and local 
enrichments and generated an empirical distribution of the maximum value observed for each 
permutation. We assigned a multiple-testing corrected p-value to each region by comparing 
  
96 
the observed differential and local enrichment values to these permutation distributions. 
We identified significant windows that had a differential p-value <0.01 and a local p-
value<0.01. 
We identified three distinct LBR binding sites from 535-1608 nucleotides (LBS-1), 9506-
10245 nucleotides (LBS-2), and 11732-11956 nucleotides (LBS-3). We also identified a 
SHARP binding site from 317-1056 nucleotides and PTBP1 binding site from 10859-11344 
nucleotides on Xist. 
Generating ΔLBS and ΔLBS-BoxB Xist 
We generated ΔLBS and ΔLBS-BoxB using CRISPR-mediated knock out. To generate 
ΔLBS and ΔLBS-BoxB cells, mouse pSM33 ES cells and Xist-BoxB cells were transfected 
with two sgRNAs flanking the LBS-1 region of Xist (sgRNA sequence: 
CACCGAGGAGCACAGCGGAC and TAAGGACGTGAGTTTCGCTT) and co-
transfected along with the Cas9 construct described above to create a deletion of LBS-1 by 
non-homologous end joining. We isolated single colonies from the transfected cells for both 
cell lines and verified that the LBS-1 region was deleted from the genome using PCR and 
Sanger sequencing with primers flanking the A-repeat region of Xist. Inversed PCR using 
the primer inside of deleted region and Sanger sequencing showed that the deleted region 
had been inserted in Chr12. We confirmed that the ΔLBS Xist transcript lacked of the deleted 
region and the deleted region was not expressed from its inserted locus by RNA-seq. We 
ensured that the ΔLBS affected binding of the LBR protein using IP-qPCR and CLIP 
sequencing across the entire Xist RNA. We also ensured that there was no impact on SHARP 
  
97 
binding using IP-qPCR. The ΔLBS RAP experiment is done in ΔLBS-BoxB cells as a 
better control for LMNB1-λN rescuing experiment. 
dCas9-KRAB silencing 
To generate stable LBR and SHARP knock down cells, we co-transfected a puromycin 
resistant construct expressing dCas9-KRAB driven by an Ef1a promoter and a guide RNA 
with scaffolding structure targeting the region near the transcription start site of LBR (sgRNA 
sequence: CGGGACTCCGCCGCGTG) or SHARP (sgRNA sequence: 
CGGTGGCGTCGGCAGCGG). Transfected cells were selected on 1 µg/mL puromycin 
(Sigma-Aldrich) for four days to enrich for cells that contain the dCas9-KRAB. We used 
FISH to verify that >90% of these puro-resistant cells had no detectable amount of mRNA 
after four days of puromycin selection. 
LBR Protein mutagenesis 
A human cDNA containing the full-length ORF of LBR was obtained from the DNASU 
plasmid repository as a Gateway entry clone and inserted into the pCAG-GW-λN-3xFLAG-
BSD vector using an LR recombination reaction (Invitrogen). To generate ΔRS-LBR and 
ΔTM-LBR, λN-3xFLAG tagged full-length LBR construct was truncated using PCR-
mediated deletion with primers flanking the deletion region. 
Expression of cDNA rescue constructs 
Mouse ES cells were electroporated using the Neon transfection system (Invitrogen) with 
mammalian expression vector (pCAG-GW-λN-3xFLAG-BSD vector) expressing human 
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ΔRS-LBR, ΔTM-LBR, or full-length LBR construct from above. We knocked down 
endogenous LBR by treating cells with siRNAs pool from Dharmacon (ON-TARGETplus 
SMARTpool siRNAs) targeting only mouse LBR, but not human LBR. We ensured that the 
siRNAs targeted the mouse LBR specifically by ensuring that the human full-length LBR 
construct could rescue cells with knock down of endogenous LBR. 
Generation of λN-3xFLAG epitope tagged proteins 
For λN-3xFLAG-tagged protein expression and immunoprecipitation, mouse ES cells were 
electroporated using the Neon transfection system (Invitrogen) with mammalian expression 
vector (pCAG-GW-λN-3xFLAG-BSD) encoding expression of a C-terminal λN-3xFLAG 
tagged ORF driven by CAG. Human ORFs of GFP, LBR, EED1 and LMNB1 were obtained 
from the DNASU plasmid repository as Gateway entry clones and inserted into pCAG-GW-
λN-3xFLAG-BSD vector using an LR recombination reaction (Invitrogen). For λN-
3xFLAG-LMNB1, the LMNB1 ORF was inserted into the vector described above but with 
a N-terminal λN-3xFLAG tag instead (pCAG-λN-3xFLAG-GW-BSD) using an LR 
recombination reaction (Invitrogen). Mouse SHARP ORF was obtained by RT-PCR from 
pSM33 total RNA using SHARP specific primers. The SHARP ORF was then cloned into a 
pENTR™/D-TOPO Gateway entry clone (Invitrogen) and inserted into the pCAG-GW-λN-
3xFLAG-BSD vector as described above. Transfected cells were selected on 4 ug/mL 
Blasticidin (InvivoGen) to enrich for cells expressing tagged proteins. For LBR-MCP, the 
LBR ORF was inserted into Ef1a-GW-MCP-V5-Neo vector using an LR recombination 
reaction (Invitrogen) and selected with 200 ug/mL Geneticin/G418 (Invitrogen). For 
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analysis, we used immunofluorescence staining with antibodies against 3xFLAG or V5 
epitope (described below) to select for cells expressing tagged proteins. 
We verified that λN-3xFLAG tagged proteins were still functional by ensuring that they 
could rescue knock down of the endogenous protein. 
Western blotting 
pSM33 cells were lysed in buffer containing 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1% 
NP-40, 0.5% sodium deoxycholate and protease inhibitor cocktail (CalBiochem; 539134) 
and sonicated using a Branson Sonifier at 25 watts for 20 seconds (0.7 seconds on, 3.3 
seconds off) on ice. ~30 μg of total protein was separated by SDS–PAGE and transferred to 
nitrocellulose membranes followed by blocking with Odyssey Blocking Buffer (Licor, 927-
40000). Primary antibodies were diluted in blocking buffer as follows: anti-FLAG® M2 
(Sigma-Aldrich; F1804) (1:1000), anti-lamin B receptor antibody (Abcam; ab122919) 
(1:1500), anti-V5 tag antibody (Abcam; ab27671) (1:1000) and anti-actin antibody (Abcam; 
ab3280) (1:1500). Secondary antibodies were diluted in 0.1% Tween-20 diluted in PBS as 
following: IRDye® 680RD Goat anti-Mouse IgG (H + L) (LI-COR; 926-68070) (1:10000) 
and IRDye® 800CW Goat anti-Rabbit IgG (H + L) (LI-COR; 926-32611) (1:10000). Blots 
were imaged with Odyssey® CLx Imager (LI-COR Biosciences) and the intensity of each 
band was quantified using ImageJ. 
 
Single molecule RNA FISH 
  
100 
Single molecule RNA Fluorescence in situ hybridization (FISH) experiments were done 
using QuantiGene ViewRNA ISH Cell Assay (Affymetrix) and QuantiGene ViewRNA ISH 
Cell 740 Module (Affymetrix) according to manufacturer’s protocol. Specifically, cells fixed 
on coverslips were first permeabilized with Detergent Solution QC at room temperature for 
5 min, and then incubated with desired mixture of probe set (Affymetrix) in Probe Set Diluent 
QF at 40°C for 3 h, followed by incubation with PreAmplifier Mix at 40°C for 30 min, 
Amplifier Mix at 40°C for 30 min, and Label Probe Mix at 40°C for 30 min sequentially. 
For DAPI staining, coverslips were incubated in 30 nM DAPI in PBS at room temperature 
for 15-20 min. Probe sets and conjugated fluorophores (excitation wavelengths) for FISH 
were TYPE 1-XIST (550 nm), TYPE 4-GPC4 (488 nm), TYPE 10-ATRX (740 nm), and 
TYPE 6-SHARP, LBR, LMNB1, EMD (650 nm). 
Immunofluorescence and RNA FISH 
For immunofluorescence (IF), cells were fixed on coverslips and permeabilized with 0.1% 
Triton-X in PBS at room temperature for 10 min, and blocked with 1X blocking buffer 
(Abcam; ab126587) or 5% normal goat serum in 0.1% Triton-X in PBS at room temperature 
for 30 min. Cells were then incubated with primary antibodies at room temperature for 1 h, 
followed by washes with 0.1% Triton-X in PBS and incubation with secondary antibodies at 
room temperature for 1 h. The samples were then processed using the RNA FISH protocol, 
as described above. Primary antibodies and the dilution used for IF were anti-Lamin B1 
(Abcam; ab16048) (1:50), and anti-FLAG® M2 (Sigma-Aldrich; F3165) (1:50), and anti-
Lamin B Receptor antibody (Abcam; ab122919) (1:100). Secondary antibodies and the 
dilution used for IF were Alexa Fluor® 488 F(ab’)2 fragment of goat anti-rabbit IgG (H+L) 
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(Life Technology; 1618692) (1:100), highly x-ads DyLight® 650 goat anti-Rabbit IgG 
(H&L) (Bethyl; A120-201D5) (1:200), DyLight® 650 goat anti-Mouse IgG (H&L) (Bethyl; 
A120-201D3) (1:200), DyLight® 550 goat anti-Rabbit IgG (H&L) (Bethyl; A90-516D5) 
(1:200) and DyLight® 650 goat anti-Mouse IgG (H&L) (Bethyl; A90-516D3) (1:200). 
Microscopic Imaging 
FISH, IF/FISH and X-chromosome paint samples were imaged using a Leica DMI 6000 
Deconvolution Microscope with the Leica HC PL APO 63x/1.30 GLYC CORR CS2 
objective. Samples stained with TYPE 10-ATRX (740 nm) were imaged using Nikon Ti 
Eclipse with the Nikon CFI Plan Apochromat λ DM 60x/1.40 oil objective. Images were 
projected with maximum projection (3 μm; step size, 0.2 μm). Samples for 3D deconvolution 
was imaged using Leica DMI 6000 Deconvolution Microscope with the Leica HC PL APO 
63x/1.30 GLYC CORR CS2 objective (15 μm; 0.02 μm step size). 3D deconvolution images 
were processed using Huygens Professional (SVI; v15.05) with the built-in theoretical point 
spread function and the classic maximum likelihood estimation method for restoration. A 
manually defined signal to noise ratio value was applied for each fluorescent channel 
respectively. Samples stained with LMNB1 or LBR were imaged using a Zeiss LSM 880 
Laser scanning confocal system with the Airyscan super-resolution module, mounted on an 
upright Axio Examiner Z1 microscope. We used a Plan-Apochromat 63x/1.40 NA Oil DIC 
f/ELYRA objective and the Airyscan module to collect super-resolution images. Single Z-
section was used for these images. 
X-chromosome Silencing Assay 
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Cells were stained for Xist RNA, Gpc4 mRNA, Atrx mRNA and siRNA-targeted mRNA 
by FISH and imaged. Images were then analyzed using Matlab R2013b (described below). 
Cells were selected if the copy number of the targeted mRNA was less than 30% of the level 
of the no siRNA treated cells and if they induced Xist expression. Within these cells, the 
copy number of Gpc4 mRNA and Atrx mRNA were quantified using a peak finding method 
(described below) and compared across conditions. We quantified mRNA levels for 50 
individual cells. We also evaluated Xist expression in siRNA-treated cells, and observed no 
difference in the percentage of cells that induced Xist expression in any of the siRNA 
conditions relative to untreated cells. 
The mean and the variance of the ratio (+Dox/-Dox) were calculated using the standard 
Taylor approximation method for estimating the significance of ratios. Accordingly, we 
calculated the average, standard deviation, and standard error of the mean as follows. 
The average (𝜇𝜇) is defined as: 
𝜇𝜇 �
+𝐷𝐷𝐷𝐷𝐷𝐷
−𝐷𝐷𝐷𝐷𝐷𝐷
� =  𝜇𝜇(+𝐷𝐷𝐷𝐷𝐷𝐷)
𝜇𝜇(−𝐷𝐷𝐷𝐷𝐷𝐷) + 𝜇𝜇(+𝐷𝐷𝐷𝐷𝐷𝐷)𝜇𝜇(−𝐷𝐷𝐷𝐷𝐷𝐷)3 𝜎𝜎2(−𝐷𝐷𝐷𝐷𝐷𝐷) 
The standard deviation (𝜎𝜎2) is defined as: 
𝜎𝜎2 �
+𝐷𝐷𝐷𝐷𝐷𝐷
−𝐷𝐷𝐷𝐷𝐷𝐷
� =  𝜎𝜎2(+𝐷𝐷𝐷𝐷𝐷𝐷)
𝜇𝜇(−𝐷𝐷𝐷𝐷𝐷𝐷)2 + 𝜇𝜇(+𝐷𝐷𝐷𝐷𝐷𝐷)2𝜇𝜇(−𝐷𝐷𝐷𝐷𝐷𝐷)4 𝜎𝜎2(−𝐷𝐷𝐷𝐷𝐷𝐷) 
and the standard error of the mean is defined as: 
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𝑆𝑆𝑆𝑆𝑆𝑆 �
+𝐷𝐷𝐷𝐷𝐷𝐷
−𝐷𝐷𝐷𝐷𝐷𝐷
� = �𝜎𝜎2 �+𝐷𝐷𝐷𝐷𝐷𝐷−𝐷𝐷𝐷𝐷𝐷𝐷�502   
Quantifying mRNAs by single molecule FISH 
All image analysis was carried out using Matlab (version R2013b) utilizing built-in functions 
from the Image Processing toolbox. Images were first filtered using a two-dimensional 
median filter to remove background. Cell boundaries were outlined manually, guided by 
DAPI staining, to create a binary mask and applied to the various channels from the same 
field of view. Top-hat morphological filtering, a background subtraction method that 
enhances the individual focal spots, was applied to the images (27). The spots were then 
identified using a 2D peak finding algorithm that identifies local maximal signals within the 
cell. Once regional maxima were identified, the number of spots was counted for each cell. 
For better visualization of spots of mRNAs, we enhanced the spot size of the images using 
Fiji (ImageJ v1.51d) Maximum Filter plugin with radius of 1.0 pixel for Gpc4 and/or Atrx 
channel.  
Calculating distance between Xist RNA compartment and Lamin B1 
The nuclei of individual cells were identified manually using the DAPI staining. We 
identified the Xist compartment by either staining for Xist RNA (FISH) or X chromosome 
DNA (chromosome paint) along with immunofluorescence for Lamin B1 protein. We 
defined the compartment by identifying a region in the nucleus using an intensity-based 
threshold to partition the image within the nucleus and find contiguous 2-dimensional regions 
of high intensity. The threshold was determined based on Otsu method as previously 
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described (28), which splits the image into 2 bins – high and low – and identifies a 
threshold that minimizes the variance within the partition. This creates a binary mask on the 
image. We visually confirmed that this binary mask accurately reflected the Xist 
compartment, X chromosome, or Lamin B1 region. The distance between the Xist 
compartment and Lamin B1 was determined by calculating the distance of each pixel 
between Xist or the X chromosome and Lamin B1 and finding the minimum value with a 
customized Fiji macro script. The area of the nucleus (Area) was measured using Fiji, and 
the radius of the nucleus (r) was calculated using 𝑟𝑟 = �𝐴𝐴𝑟𝑟𝐴𝐴𝐴𝐴 𝜋𝜋⁄ . We set the distance as zero 
if the Lamin B1 fluorescence signal overlapped with the fluorescence signal detect for Xist 
or the X chromosome (respectively). 
Calculating distance between the Xist compartment and genomic loci 
The nuclear area and Xist compartment were identified using the method described above. 
Genomic loci were determined by RNA FISH with probes against the intronic region of the 
genes using smFISH (29) as described above (TYPE 4-GPC4 (Intron1) (488 nm)). We then 
identified the spot with Analyze Particle function in Fiji and selecting the spot with highest 
fluorescent intensity within the nucleus. We discarded the small number of images that 
contained more than one spot. For the GPC4 locus in male cells, the distance between the 
Xist compartment and the locus was determined by finding the minimum distance between 
Xist compartment and the locus with a customized Fiji macro script described above. For 
GPC4 in female ES cell, the distance between the Xist compartment and the loci was 
determined by calculating the minimum distance between Xist compartment and either one 
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of the two loci. Median values and the standard error of the median were plotted in the 
figures. We calculated the standard error of the median as standard error of the median = 
1.2533(standard error of the mean) 
We identified loci as inside the Xist compartment if the fluorescence signal of the locus 
overlapped with these fluorescence signal for Xist (for XIST and male ES cell GPC4). 
RNA antisense purification (RAP) coupled with DNA sequencing 
10 million mouse ES cells were induced with  doxycycline for 6 , lysates were prepared, and 
Xist RNA was captured and purified as previously described (7). For Xist RNA capture, we 
used antisense 5’ biotinylated 90-mer DNA oligonucleotides (Eurofins Operon) that spanned 
the entire length of the Xist RNA as previously described (11). To elute captured DNA, we 
incubated the beads with 15 U RNase H in 20 uL RNase H buffer (NEB Biolabs) at 37°C for 
1 hour. The RNase H digested samples were then transferred to a new tube. To reverse 
crosslinks, we added 25 uL Hybridization Buffer (20 mM Tris-HCl (pH 7.5), 7 mM EDTA, 
3 mM EGTA, 150 mM LiCl, 1% NP-40, 0.2% N-lauroylsarcosine, 0.125% Na-
Deoxycholate, 3M Guanidinium Thiocyanate, 2.5mM TCEP), 125 uL NLS Elution Buffer 
(20 mM Tris-HCl (pH 7.5), 10 mM EDTA, 2% N-lauroylsarcosine, 2.5mM TCEP), 500 mM 
NaCl and 4 U Protease K (NEB Biolabs, Molecular Biology Grade) and incubated at 60°C 
overnight. Eluted DNA was sequenced, aligned and analyzed as previously described (7, 26). 
Aggregate gene analysis  
  
106 
We calculated the metaplot by first scaling the number of reads in each sample to obtain 
the same total number of reads for all the samples in 1 kb windows. We then normalized 
each sample to its own input followed by a second normalization to the wild-type Xist sample 
to obtain the relative ratio of each window. We then plotted the log-ratio of these values 100 
Kb upstream and downstream of each gene on X-chromosome along with the gene body 
region, which was scaled across genes to represent the same overall area. To avoid 
overcounting, when we extended a given gene, we only included those extensions in our 
aggregation set if they were not already included in the left or right extensions from a 
previous gene. Genes within 5 Mb of the Xist transcription locus were excluded from the 
analysis because they represent outliers in terms of average Xist enrichment. The plots were 
generated and visualized using DeepTools and Gviz. The “active” and “inactive” genes were 
defined as previously described (7). Expression levels were split based on RPKM levels 
computed from chromatin RNA-Seq levels as previously described (26). We only considered 
genes with RPKM expression >1. Genes with RPKM expression >5 are grouped as highly 
actively transcribed genes.  
The regional normalization curve was obtained by calculating a smoothed running average 
across a 10-kilobase window on the chromosome. Accordingly, it was included to 
demonstrate the overall pattern of the data, which can be more easily seen in a smoothed 
aggregate representation relative to overlay of each individual data point. Each number in 
the plot (Wi) was calculated using the simple mean of the 1-kilobase pair windows shown in 
the top panel, such that: 
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C h a p t e r  5  
CONCLUSION AND FUTURE DIRECTIONS 
5.1    Conclusion 
With RAP-MS, we are able to identify three Xist direct-interacting proteins, SAF-A, SHARP 
and LBR, that are required for Xist-mediated chromosome-wide silencing. While previous 
studies have shown that SAF-A is required for Xist to localize on the chromatin(1), by 
characterizing the roles SHARP and LBR play in the process, we suggest a model for how 
the interaction between Xist and these three proteins can orchestrate chromosome-wide 
transcriptional silencing on Xi (Figure 5.1). 
Upon initiation of Xist expression (Figure 5.1; left panel), Xist spreads to regions (Figure 
5.1; black regions) that are closest to the Xist transcription locus (Figure 5.1; red arrow) 
by binding to the SAF-A protein on chromatin(1, 7, 8). Xist recruits the SHARP protein and 
its associated SMRT complex(2-4) to these initial sites. This Xist-SHARP complex can then 
act to either directly recruit HDAC3 to the X-chromosome or exploit HDAC3 that may 
already be present at active genes across the X-chromosome(5, 6) and induce its enzymatic 
activity by bringing it into proximity with its required SMRT co-repressor(7, 8) at Xist target 
sites across the X-chromosome. Through the activity of HDAC3, Xist can direct the removal 
of activating histone acetylation marks on chromatin thereby compacting chromatin(9-11) 
and silencing transcription(6, 12, 13). Then, these initial Xist-coated DNA regions (Figure 
5.1; black regions) sample different locations of the nucleus(44, 45, 23, 46, 47) and when 
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they come into close proximity of the nuclear lamina, are sequestered at the nuclear 
lamina through an interaction between Xist and LBR (Figure 5.1; middle panel). Because 
DNA that interacts with the nuclear lamina undergoes more constrained mobility(23, 24), 
this recruitment changes the 3-dimensional organization of X-chromosome(15, 48, 49) and 
repositions active genes (Figure 5.1; green regions) closer the Xist transcription locus 
enabling Xist, and its SHARP/SMRT/HDAC3 silencing complex(11, 18, 22), to spread to 
these new sites by 3-dimensional proximity transfer. These sites are then recruited to the 
nuclear lamina, effectively bringing another set of active genes (Figure 5.1; yellow regions) 
into closer contact with the Xist transcription locus (Figure 5.1; right panel). Because the 
Xist transcription locus escapes Xist coating and silencing, it is positioned away from the 
nuclear lamina(7, 8, 5, 2, 1) and therefore will be close to sites that have not yet been coated 
and silenced by Xist. This iterative process would enable Xist to spread to, and silence, 
actively transcribed genes across the entire X-chromosome. 
Xist has long represented a mechanistic paradigm for understanding other lncRNAs, but this 
is largely because we lacked the tools required to probe any specific lncRNA. Accordingly, 
most work has focused on the role of lncRNAs in the regulation of gene expression through 
the recruitment of chromatin regulatory proteins – primarily PRC2. Our results highlight the 
importance of identifying direct lncRNA-interacting proteins for deciphering lncRNA 
mechanisms of action. Even for Xist, where we know a tremendous amount about its 
molecular functions, we uncovered a novel mechanism for its ability to silence transcription. 
There are likely to be many additional mechanisms of action for lncRNAs, including roles 
in the nucleoplasm and cytoplasm. Identifying the proteins that interact with any given 
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lncRNA will be an important step towards deciphering these mechanisms. Importantly, 
RAP-MS provides a critical tool for achieving this goal and will accelerate the discovery of 
novel lncRNA mechanisms that have thus far proved elusive. 
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Figure 5.1. A model for how Xist-mediated recruitment to the nuclear lamina enables 
spreading to active genes and transcriptional silencing on the X chromosome. Xist 
initially localizes to the core of the X chromosome territory by localizing at DNA sites that 
are in close 3D proximity to its transcriptional locus. These initial Xist localization sites are 
generally inactive prior to Xist induction. The Xist-coated DNA, like other chromosomal 
DNA regions, will dynamically sample different nuclear locations and, because Xist binds 
LBR, will become tethered at the nuclear lamina when it comes into spatial proximity. This 
lamina association is known to constrain chromosomal mobility and by doing so would 
position the Xist-coated DNA away from the actively transcribed Xist transcription locus. 
This would enable other DNA regions on the X chromosome, which are physically linked to 
these tethered regions, to be brought into closer spatial proximity to the Xist transcription 
locus. In this way, Xist and its silencing factors can spread to these newly accessible DNA 
regions on the X chromosome.  
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5.2   Future Directions 
Although we have identified the direct Xist-interacting proteins and demonstrated a model 
for the mechanism of Xist-mediated silencing, some questions remain unclear during the 
process of XCI. For example, although Xist can spread across the entire X chromosome, 
some genes on Xi, including Xist itself, can escape from Xist-mediated silencing and 
remain actively transcribed(14). Genome-wide analysis of Xist associated DNA on Xi 
reveals that Xist is depleted from the regions of these escaping genes and their 
promoters(15). The result suggests that the escapees escape from Xist-mediated silencing 
by preventing Xist binding to the regions. Furthermore, the depleted Xist association is 
unlikely result from the features of the DNA sequences of these escapees, since no common 
sequences have been identified among escapees. Also, the depleted Xist association could 
not be simply explained by the interaction between Xist and SAF-A, since SAF-A showed 
homogenous chromatin association across the entire X chromosome. It is possible that the 
depleted Xist association is due to the spatial separation between Xist and the escapees, 
which makes Xist unable to access to the regions by 3D proximity search. This hypothesis 
is supported by a recent study showing that changing the chromosome organization of Xi 
can lead to lower expression level of certain escapees(16). However, further studies are 
required to identify the components involved in the process, which may help us to reveal 
the mechanism of escaping Xist-mediated silencing. Although escapee only contributes a 
small fraction among the genes on X chromosome (~20-80 in mouse depending on 
different cell types)(14, 16), studies have suggested that some escapees may be related to 
some clinical features of polyX karyotypes in humans(17). Therefore, studying the 
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mechanism of escaping may also provide us some clinical insights of how to 
compensate the dosage difference of certain escapees for polyX karyotypes patients. 
Another interesting question waiting to be answered is that how the maintenance state of 
Xist-mediated silencing is established. At the late stage of XCI, the CpG island of the 
promoter regions of silenced genes on Xi is heavily methylated(18, 19). One possible 
model is that once the DNA methylation has been established de novo by DNMT3A/B, the 
silencing state can be maintained by DNMT1-mediated self-propagation of DNA 
methylation pattern(20). But how is DNMT1 recruited to the target sites across the entire 
Xi at the first place? Since Xist is capable of spreading across the entire Xi, it is likely that 
DNMT1 is recruited to Xi through an Xist-mediated mechanism. However, since DNMT1 
is not identified as one of the Xist-interacting proteins, either directly or indirectly(21-23), 
it is possible that DNMT1 is recruited to the target sites through a secondary downstream 
event of Xist spreading and silencing. Some studies suggested that SMCHD1, a protein 
interacting with Xist indirectly, plays a role in DNMT1 recruitment(24, 25). However, the 
CpG island methylation still occurs in some silenced genes, which suggests another 
Smchd1-independent pathway of DNA methylation(25). Therefore, further studies are 
required to identify the other components that are involved in the transition from the 
initiation state to the maintenance state of Xist-mediated silencing, which may provide us 
some insights into the mechanism of establishing XCI maintenance and the role Xist plays 
in this process.  
In sum, by identifying Xist-interacting proteins, we show how a lncRNA can function as a 
scaffold which orchestrates various events through recruiting different proteins to specific 
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loci. The methods we used enable us reveal some unknown mechanism of Xist-
mediated events that occur during XCI. In addition to Xist, we now have the opportunity 
to study the molecular mechanism of other lncRNAs with either known or unknown 
function. I believe that with Xist as an example, a door has been opened for us to study the 
functions of various lncRNAs and explore their molecular mechanisms! 
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